
<html lang="en"     class="pb-page"  data-request-id="31201b82-205a-421e-9693-1effb44fa9b6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.9b01140;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-20;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose" /></meta><meta name="dc.Creator" content="Genta  Tadano" /></meta><meta name="dc.Creator" content="Kazuo  Komano" /></meta><meta name="dc.Creator" content="Shuhei  Yoshida" /></meta><meta name="dc.Creator" content="Shinji  Suzuki" /></meta><meta name="dc.Creator" content="Kenji  Nakahara" /></meta><meta name="dc.Creator" content="Kouki  Fuchino" /></meta><meta name="dc.Creator" content="Kazuki  Fujimoto" /></meta><meta name="dc.Creator" content="Eriko  Matsuoka" /></meta><meta name="dc.Creator" content="Takahiko  Yamamoto" /></meta><meta name="dc.Creator" content="Naoya  Asada" /></meta><meta name="dc.Creator" content="Hisanori  Ito" /></meta><meta name="dc.Creator" content="Gaku  Sakaguchi" /></meta><meta name="dc.Creator" content="Naoki  Kanegawa" /></meta><meta name="dc.Creator" content="Yasuto  Kido" /></meta><meta name="dc.Creator" content="Shigeru  Ando" /></meta><meta name="dc.Creator" content="Tamio  Fukushima" /></meta><meta name="dc.Creator" content="Ard  Teisman" /></meta><meta name="dc.Creator" content="Vijay  Urmaliya" /></meta><meta name="dc.Creator" content="Deborah  Dhuyvetter" /></meta><meta name="dc.Creator" content="Herman  Borghys" /></meta><meta name="dc.Creator" content="An  Van Den Bergh" /></meta><meta name="dc.Creator" content="Nigel  Austin" /></meta><meta name="dc.Creator" content="Harrie J. M.  Gijsen" /></meta><meta name="dc.Creator" content="Yoshinori  Yamano" /></meta><meta name="dc.Creator" content="Yasuyoshi  Iso" /></meta><meta name="dc.Creator" content="Ken-ichi  Kusakabe" /></meta><meta name="dc.Description" content="Genetic evidence points to deposition of amyloid-β (Aβ) as a causal factor for Alzheimer’s disease. Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein. Starti..." /></meta><meta name="Description" content="Genetic evidence points to deposition of amyloid-β (Aβ) as a causal factor for Alzheimer’s disease. Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein. Starti..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 24, 2019" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01140" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01140" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01140" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01140" /></link>
        
    
    

<title>Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01140" /></meta><meta property="og:title" content="Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0009.jpeg" /></meta><meta property="og:description" content="Genetic evidence points to deposition of amyloid-β (Aβ) as a causal factor for Alzheimer’s disease. Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein. Starting with an oxazine lead 1, we describe the discovery of a thiazine-based BACE1 inhibitor 5 with robust Aβ reduction in vivo at low concentrations, leading to a low projected human dose of 14 mg/day where 5 achieved sustained Aβ reduction of 80% at trough level." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01140"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01140">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01140&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01140&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01140&amp;href=/doi/10.1021/acs.jmedchem.9b01140" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 9331-9337</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01340" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Brief Article</span><a href="/doi/10.1021/acs.jmedchem.9b01539" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Genta Tadano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Genta Tadano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Genta++Tadano">Genta Tadano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kazuo Komano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kazuo Komano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kazuo++Komano">Kazuo Komano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shuhei Yoshida</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuhei Yoshida</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuhei++Yoshida">Shuhei Yoshida</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shinji Suzuki</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shinji Suzuki</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shinji++Suzuki">Shinji Suzuki</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kenji Nakahara</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kenji Nakahara</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kenji++Nakahara">Kenji Nakahara</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kouki Fuchino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kouki Fuchino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kouki++Fuchino">Kouki Fuchino</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kazuki Fujimoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kazuki Fujimoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kazuki++Fujimoto">Kazuki Fujimoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eriko Matsuoka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eriko Matsuoka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eriko++Matsuoka">Eriko Matsuoka</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Takahiko Yamamoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Takahiko Yamamoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Takahiko++Yamamoto">Takahiko Yamamoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Naoya Asada</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Naoya Asada</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Naoya++Asada">Naoya Asada</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hisanori Ito</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hisanori Ito</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hisanori++Ito">Hisanori Ito</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gaku Sakaguchi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gaku Sakaguchi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gaku++Sakaguchi">Gaku Sakaguchi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Naoki Kanegawa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Naoki Kanegawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Laboratory for Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Naoki++Kanegawa">Naoki Kanegawa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yasuto Kido</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yasuto Kido</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Laboratory for Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yasuto++Kido">Yasuto Kido</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shigeru Ando</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shigeru Ando</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Laboratory for Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shigeru++Ando">Shigeru Ando</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tamio Fukushima</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tamio Fukushima</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Laboratory for Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tamio++Fukushima">Tamio Fukushima</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ard Teisman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ard Teisman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Non-Clinical Safety, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ard++Teisman">Ard Teisman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vijay Urmaliya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vijay Urmaliya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Non-Clinical Safety, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vijay++Urmaliya">Vijay Urmaliya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deborah Dhuyvetter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deborah Dhuyvetter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Non-Clinical Safety, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deborah++Dhuyvetter">Deborah Dhuyvetter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Herman Borghys</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Herman Borghys</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Non-Clinical Safety, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Herman++Borghys">Herman Borghys</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">An Van Den Bergh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">An Van Den Bergh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=An++Van+Den+Bergh">An Van Den Bergh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nigel Austin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nigel Austin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nigel++Austin">Nigel Austin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Harrie J. M. Gijsen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Harrie J. M. Gijsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Harrie+J.+M.++Gijsen">Harrie J. M. Gijsen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8020-4828" title="Orcid link">http://orcid.org/0000-0001-8020-4828</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yoshinori Yamano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yoshinori Yamano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yoshinori++Yamano">Yoshinori Yamano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yasuyoshi Iso</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yasuyoshi Iso</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yasuyoshi++Iso">Yasuyoshi Iso</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ken-ichi Kusakabe</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ken-ichi Kusakabe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +81-6-6331-6190. Fax: +81-6-6332-6385. E-mail: <a href="/cdn-cgi/l/email-protection#79121c1754101a111057120c0a1812181b1c390a11101617161e10571a16571309"><span class="__cf_email__" data-cfemail="e8838d86c5818b8081c6839d9b8983898a8da89b80818786878f81c68b87c68298">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ken-ichi++Kusakabe">Ken-ichi Kusakabe</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9055-8267" title="Orcid link">http://orcid.org/0000-0001-9055-8267</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01140&amp;href=/doi/10.1021%2Facs.jmedchem.9b01140" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 9331–9337</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 24, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 July 2019</li><li><span class="item_label"><b>Published</b> online</span>24 September 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 October 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01140" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01140</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9331%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGenta%2BTadano%252C%2BKazuo%2BKomano%252C%2BShuhei%2BYoshida%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D20%26contentID%3Dacs.jmedchem.9b01140%26title%3DDiscovery%2Bof%2Ban%2BExtremely%2BPotent%2BThiazine-Based%2B%25CE%25B2-Secretase%2BInhibitor%2Bwith%2BReduced%2BCardiovascular%2Band%2BLiver%2BToxicity%2Bat%2Ba%2BLow%2BProjected%2BHuman%2BDose%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9337%26publicationDate%3DOctober%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01140"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1246</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01140" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Genta&quot;,&quot;last_name&quot;:&quot;Tadano&quot;},{&quot;first_name&quot;:&quot;Kazuo&quot;,&quot;last_name&quot;:&quot;Komano&quot;},{&quot;first_name&quot;:&quot;Shuhei&quot;,&quot;last_name&quot;:&quot;Yoshida&quot;},{&quot;first_name&quot;:&quot;Shinji&quot;,&quot;last_name&quot;:&quot;Suzuki&quot;},{&quot;first_name&quot;:&quot;Kenji&quot;,&quot;last_name&quot;:&quot;Nakahara&quot;},{&quot;first_name&quot;:&quot;Kouki&quot;,&quot;last_name&quot;:&quot;Fuchino&quot;},{&quot;first_name&quot;:&quot;Kazuki&quot;,&quot;last_name&quot;:&quot;Fujimoto&quot;},{&quot;first_name&quot;:&quot;Eriko&quot;,&quot;last_name&quot;:&quot;Matsuoka&quot;},{&quot;first_name&quot;:&quot;Takahiko&quot;,&quot;last_name&quot;:&quot;Yamamoto&quot;},{&quot;first_name&quot;:&quot;Naoya&quot;,&quot;last_name&quot;:&quot;Asada&quot;},{&quot;first_name&quot;:&quot;Hisanori&quot;,&quot;last_name&quot;:&quot;Ito&quot;},{&quot;first_name&quot;:&quot;Gaku&quot;,&quot;last_name&quot;:&quot;Sakaguchi&quot;},{&quot;first_name&quot;:&quot;Naoki&quot;,&quot;last_name&quot;:&quot;Kanegawa&quot;},{&quot;first_name&quot;:&quot;Yasuto&quot;,&quot;last_name&quot;:&quot;Kido&quot;},{&quot;first_name&quot;:&quot;Shigeru&quot;,&quot;last_name&quot;:&quot;Ando&quot;},{&quot;first_name&quot;:&quot;Tamio&quot;,&quot;last_name&quot;:&quot;Fukushima&quot;},{&quot;first_name&quot;:&quot;Ard&quot;,&quot;last_name&quot;:&quot;Teisman&quot;},{&quot;first_name&quot;:&quot;Vijay&quot;,&quot;last_name&quot;:&quot;Urmaliya&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;Dhuyvetter&quot;},{&quot;first_name&quot;:&quot;Herman&quot;,&quot;last_name&quot;:&quot;Borghys&quot;},{&quot;first_name&quot;:&quot;An&quot;,&quot;last_name&quot;:&quot;Van Den Bergh&quot;},{&quot;first_name&quot;:&quot;Nigel&quot;,&quot;last_name&quot;:&quot;Austin&quot;},{&quot;first_name&quot;:&quot;Harrie&quot;,&quot;last_name&quot;:&quot;J. M. Gijsen&quot;},{&quot;first_name&quot;:&quot;Yoshinori&quot;,&quot;last_name&quot;:&quot;Yamano&quot;},{&quot;first_name&quot;:&quot;Yasuyoshi&quot;,&quot;last_name&quot;:&quot;Iso&quot;},{&quot;first_name&quot;:&quot;Ken-ichi&quot;,&quot;last_name&quot;:&quot;Kusakabe&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;9331-9337&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01140&quot;},&quot;abstract&quot;:&quot;Genetic evidence points to deposition of amyloid-β (Aβ) as a causal factor for Alzheimer’s disease. Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein. Starting with an oxazine lead 1, we describe the discovery of a thiazine-based BACE1 inhibitor 5 with robust Aβ reduction in vivo at low concentrations, leading to a low projected human dose of 14 mg/day where 5 achieved sustained Aβ reduction of 80% at trough level.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01140&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01140" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01140&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01140" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01140&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01140" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01140&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01140&amp;href=/doi/10.1021/acs.jmedchem.9b01140" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01140" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01140" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1009 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01140%26sid%3Dliteratum%253Aachs%26pmid%3D31549838%26genre%3Darticle%26aulast%3DTadano%26date%3D2019%26atitle%3DDiscovery%2Bof%2Ban%2BExtremely%2BPotent%2BThiazine-Based%2B%25CE%25B2-Secretase%2BInhibitor%2Bwith%2BReduced%2BCardiovascular%2Band%2BLiver%2BToxicity%2Bat%2Ba%2BLow%2BProjected%2BHuman%2BDose%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D20%26spage%3D9331%26epage%3D9337%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=290860" title="Solution chemistry">Solution chemistry</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/jmcmar.2019.62.issue-20/20191024/jmcmar.2019.62.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01140&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Genetic evidence points to deposition of amyloid-β (Aβ) as a causal factor for Alzheimer’s disease. Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein. Starting with an oxazine lead <b>1</b>, we describe the discovery of a thiazine-based BACE1 inhibitor <b>5</b> with robust Aβ reduction in vivo at low concentrations, leading to a low projected human dose of 14 mg/day where <b>5</b> achieved sustained Aβ reduction of 80% at trough level.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most common form of dementia and constitutes a massive health care burden.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Genetic evidence of autosomal dominant AD mutations in the amyloid precursor protein (APP) and presenilin genes provides support for the Aβ hypothesis of accumulation amyloid-β (Aβ) being a causative factor of AD.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The Icelandic mutation observed in APP, A673T, further supports this hypothesis, as the mutation protects against AD and cognitive impairment in elderly individuals.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The β-site amyloid precursor protein cleaving enzyme 1 (BACE1; also known as β-secretase) is a rate-limiting enzyme for the production of Aβ, along with the γ-secretase complex, and is one of the prime targets for AD therapeutics.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> BACE1 inhibitors have been pursued by a number of pharmaceutical companies and academic institutes,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> culminating in clinical compounds reaching Phase III clinical trials, such as verubecestat (MK-8931; Merck),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> lanabecestat (AZD-3293; AstraZeneca and Eli Lilly),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> elenbecestat (E-2609; Eisai and Biogen),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> umibecestat (CNP-520; Novartis and Amgen),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and atabecestat (JNJ-54861911; Janssen and Shionogi).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Of these, verubecestat<a onclick="showRef(event, 'cit6c'); return false;" href="javascript:void(0);" class="ref cit6c">(6c)</a> and lanabecestat<a onclick="showRef(event, 'cit7b'); return false;" href="javascript:void(0);" class="ref cit7b">(7b)</a> were unfortunately discontinued due to lack of efficacy, and atabecestat failed due to serious elevations of liver enzymes.<a onclick="showRef(event, 'cit10b'); return false;" href="javascript:void(0);" class="ref cit10b">(10b)</a> Recently, the discontinuation of the clinical development of umibecestat was announced, as it caused decline in cognitive function.<a onclick="showRef(event, 'cit9b'); return false;" href="javascript:void(0);" class="ref cit9b">(9b)</a></div><div class="NLM_p">Our research efforts of exploring back-up molecules for atabecestat started in 2011, in order to mitigate the issues observed in preclinical investigations in terms of cardiovascular and liver toxicity, such as a low hERG IC<sub>50</sub> value and elevations of liver enzymes in high dose in vivo toxicology studies. Thus, our initial objectives were to mitigate these issues along with achieving a low projected human dose and structural differentiation. Our early efforts led to the identification of an oxazine series, such as compound <b>1</b> with minimal cardiovascular safety concerns related to hERG inhibition as well as structurally differentiated compounds.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The work presented here builds on this series, leading to the discovery of compound <b>5</b> with a low human projected dose and no significant concerns with respect to cardiovascular safety and liver toxicity in vivo (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>).</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. BACE1 Inhibitors <b>1</b> and <b>5</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01140&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Inhibitor Design</h3><div class="NLM_p">Minimizing the maximum daily dose of a drug candidate is a key strategy to mitigating toxicity risks in clinical applications. Analysis of the top 200 drugs in the United States by Stepan et al. revealed that a maximum daily dose of 100 mg or less significantly reduced the incidence of drugs withdrawn and a black box warning due to idiosyncratic toxicity; more importantly, a daily dose of 10 mg or less led to complete avoidance of the risk.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> With these points in mind, our medicinal chemistry efforts started with <b>1</b> to achieve a low human projected dose. Our SAR efforts related to <b>1</b> revealed the following: 1) an optimal p<i>K</i><sub>a</sub> range of 6.5 to 7.4 could avoid high hERG inhibition and P-gp efflux as well as retain cellular potency;<a onclick="showRef(event, 'cit11b'); return false;" href="javascript:void(0);" class="ref cit11b">(11b)</a> 2) high potency was realized when incorporating substituents at the 5- and 6-positions via active conformation stabilization;<a onclick="showRef(event, 'cit11a'); return false;" href="javascript:void(0);" class="ref cit11a">(11a)</a> and 3) favorable ADMET profiles, including hERG inhibition, P-gp efflux, and metabolic stability, were achieved by incorporating fluoromethoxypyrazine.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, comparative analysis of our early leads <b>2</b> and <b>3</b><a onclick="showRef(event, 'cit11a cit11b'); return false;" href="javascript:void(0);" class="ref cit11a cit11b">(11a,b)</a> indicated that replacing the oxazine ring in <b>1</b> by thiazine<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> leading to <b>A</b> could provide further gain in potency (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), whereas the basicity needed to be fine-tuned further as it was predicted to be below p<i>K</i><sub>a</sub> 6.5 resulting in reduced cellular potency. The p<i>K</i><sub>a</sub> value of the 5-fluoro oxazine <b>4</b><a onclick="showRef(event, 'cit11b'); return false;" href="javascript:void(0);" class="ref cit11b">(11b)</a> (p<i>K</i><sub>a</sub> = 8.1) as well as the difference in p<i>K</i><sub>a</sub> between thiazine <b>2</b> and oxazine <b>3</b> (Δp<i>K</i><sub>a</sub> = 0.8) led to the design of compound <b>5</b> with a predicted p<i>K</i><sub>a</sub> value of 7.3 retaining the other key structural features in the lead <b>1</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. p<i>K</i><sub>a</sub> and BACE IC<sub>50</sub> Values for the Initial Leads</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0006.gif" alt="" id="GRAPHIC-d7e580-autogenerated" /></img><div></div></div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of compound <b>5</b> from the lead <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01140&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Chemistry</h3><div class="NLM_p">Synthesis of the thiazine <b>5</b> began with treatment of ester <b>6</b><a onclick="showRef(event, 'cit11a'); return false;" href="javascript:void(0);" class="ref cit11a">(11a)</a> with diisobutylaluminum hydride (DIBAL) followed by the Wittig reaction using methyltriphenylphosphonium bromide to give compound <b>7</b>. Following deprotection of the Boc group in <b>7</b>, the thiazine scaffold was formed with benzoyl isothiocyanate and iodine to afford <b>9</b> via intermediate <b>8</b>.<a onclick="showRef(event, 'cit11a'); return false;" href="javascript:void(0);" class="ref cit11a">(11a)</a> Reductive dehalogenation and deprotection of <b>10</b> resulted in <b>11</b> followed by incorporation of the amide moiety via a three-step sequence allowed access to the final compound <b>5</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01140&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) DIBAL, DCM, −78 °C, (ii) MePPh<sub>3</sub>Br, KO<i>t</i>-Bu, toluene, rt, 39%; (b) (i) HCl in dioxane, DCM, rt, (ii) BzNCS, DCM, rt, 95%; (c) I<sub>2</sub>, MeCN, 0 °C, 82%; (d) <i>n</i>-Bu<sub>3</sub>SnH, AIBN, toluene, 80 °C, 90%; (e) hydrazine monohydrate, EtOH, rt, 91%; (f) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>-TFA, −20 °C, (ii) Fe, NH<sub>4</sub>Cl, toluene-H<sub>2</sub>O, 80 °C, (iii) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, HCl, EDC·HCl, MeOH, 0 °C to rt, 91%.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Vitro and PK Profiling</h3><div class="NLM_p last">Compared to the lead <b>1</b>, the thiazine <b>5</b> was shown to possess a 2- to 3-fold increase in biochemical and cellular potency (BACE1 HTRF IC<sub>50</sub> = 5.0 nM, cellular Aβ<sub>40</sub> IC<sub>50</sub> = 0.38 nM). Compound <b>5</b> showed excellent selectivity over cathepsin D (IC<sub>50</sub> = >100 μM) and minimal selectivity over BACE2 (HTRF IC<sub>50</sub> = 7.1 nM). As expected, the designed thiazine <b>5</b> exhibited an optimal p<i>K</i><sub>a</sub> value of 7.3, which translated into low hERG inhibitory activity and P-gp recognition in LLC-PK1 cells expressing human MDR1 (hERG inhibition at 3 μM = 31% (IC<sub>50</sub> = 5.1 μM), P-gp efflux ratio = 1.1). Like compound <b>1</b>, thiazine <b>5</b> was metabolically stable in human and dog hepatocytes after 2 h incubation at 2 μM (89% and 90% remaining, respectively), whereas in those of rat, mouse, and cynomolgus monkey, it showed moderate-to-good stability (74%, 71%, and 55%, respectively). In terms of inhibition of CYP enzymes, <b>5</b> exhibited no significant inhibition of CYP1A2, CYP2C19, and CYP3A4 (IC<sub>50</sub> = >20 μM), whereas a moderate inhibition was observed in CYP2C9 and CYP2D6 (IC<sub>50</sub> = 3.5 μM and 3.3 μM, respectively). The fraction unbound in plasma (<i>f</i><sub>u,p</sub>) for human, rat, mouse, dog, and monkey was measured to be 0.083, 0.12, 0.15, 0.078, and 0.12, respectively, and the fraction unbound in the rat brain homogenate (<i>f</i><sub>u,b</sub>) was 0.034. The experimental Log <i>D</i> at pH 7.4 and permeability in LLC-PK1 cells were 2.4 and 22.7 × 10<sup>–6</sup> cm/s, respectively; aqueous solubility at pH 1.2 and 6.8 was >1000 μg/mL and 28.2 μg/mL, respectively, demonstrating good physicochemical profiles. Reflecting the favorable in vitro ADME profiles, preliminary pharmacokinetic (PK) screening in rat exhibited a low-to-moderate clearance (24.8 mL/min/kg), a moderate-to-good <i>C</i><sub>max</sub> (38.4 ng/mL), an acceptable bioavailability (31%), and high brain-to-total plasma and brain-to-free plasma concentration ratios (<i>K</i><sub>p</sub> = 3.3, <i>K</i><sub>p,uu</sub> = 0.95, respectively) at a po dose of 1 mg/kg and an iv dose of 0.5 mg/kg. On the basis of the favorable in vitro pharmacological as well as ADME profiles, compound <b>5</b> was selected for pharmacokinetic/pharmacodynamic (PK/PD) characterization.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> PK/PD Study</h3><div class="NLM_p">The PK/PD profile of <b>5</b> was characterized in mouse and dog.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In mouse, <b>5</b> showed dose-dependent inhibitions of Aβ at 1 and 3 mg/kg (<i>n</i> = 4), where total Aβ in the brain was measured at 2, 4, and 6 h postdosing (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Compound <b>5</b> reached maximal Aβ reduction of 90% at 3 mg/kg and reduced Aβ by 55% at a dose as low as 1 mg/kg with a brain concentration of 37 ng/mL (87 nM; 3.0 nM free). At 3 mg/kg, sustained Aβ reduction was observed because the brain level at 6 h (611 nM; 73 nM free) clearly exceeded a cellular IC<sub>50</sub> value of 0.38 nM. Beagle dogs received 0.08, 0.16, 0.31, and 1.25 mg/kg oral doses of <b>5</b>. Plasma samples were taken at 0.5, 1, 2, 4, 8, 25, and 49 h, and cerebrospinal fluid (CSF) was sampled in conscious animals from the lateral ventricle before dosing and at 4, 8, 25, and 49 h. A single oral dose of <b>5</b> also produced robust and dose-dependent Aβ<sub>42</sub> reductions in the CSF. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, maximal Aβ<sub>42</sub> reductions (∼80%) were achieved at 1.25 mg/kg, and <b>5</b> achieved 50% reduction even at 0.08 mg/kg. Consistent with the high <i>K</i><sub>p,uu</sub> in rat and mouse as well as the low P-gp efflux ratio, the CSF-to-unbound plasma concentration ratio in dog was measured to be 0.77 (an average of 0.08, 0.16, and 0.31 mg/kg). Finally, the plasma EC50 and EC80 values to lower CSF Aβ<sub>42</sub> by 50% and 80% were determined to be 8.9 ng/mL (21 nM) and 44 ng/mL (100 nM), respectively, resulting in a low unbound EC<sub>50</sub> (EC<sub>50,u</sub>) of 0.69 ng/mL (1.8 nM; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). We were also interested in the comparison of potency in dog between <b>5</b> and the clinical compounds verubecestat and elenbecestat. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, compound <b>5</b> was found to be more potent than both on considering the EC<sub>50,u</sub> values.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time course effects of <b>5</b> on total brain Aβ reduction (vs vehicle control), plasma, and brain concentrations in male Crl:CD1 (ICR) mice (6 to 8 weeks old, <i>n</i> = 4) after 1 and 3 mg/kg oral doses as a solution of 20% hydroxypropyl-β-cyclodextrin (HPBCD).<a onclick="showRef(event, 'cit11a cit11b'); return false;" href="javascript:void(0);" class="ref cit11a cit11b">(11a,b)</a> Total Ab reductions (% reduction; red) and brain concentrations (ng/g; black) are shown by solid lines, and plasma concentrations (ng/mL; black) are shown by dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01140&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. CSF Aβ<sub>42</sub> reduction in beagle dogs after oral dose of compound <b>5</b> as a solution in 20% HPBCD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01140&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Dog EC<sub>50</sub> Values for <b>5</b>, Verubecestat, and Elenbecestat</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50,u</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">verubecestat</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">elenbecestat</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">8.1</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Human Dose Projection</h3><div class="NLM_p">Prior to generating human dose projections, PK parameters of <b>5</b> were determined in rat, mouse, dog, and monkey (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Reflecting the stability in hepatocytes, clearance in dog was low (3 mL/min/kg), whereas that in mouse, rat, and monkey was found to be moderate-to-high. Indeed, the low clearance in dog was translated into a high bioavailability of 95%; the others were found to be moderate (24 to 58%). For atabecestat with a thiazine scaffold, the shape of the PK profile was better predicted using the Dedrick approach<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> compared to the allometric scaling approach. Therefore, we thought it appropriate to rely on the Dedrick approach for <b>5</b>. To predict human dosage, the following assumptions were made: an absorption rate (<i>k</i><sub>a</sub>) of 0.47 (identical to atabecestat) and an oral bioavailability of 54% (average from preclinical species testing), where the target plasma trough levels (<i>C</i><sub>trough</sub>) were set at the EC<sub>50</sub> and EC<sub>80</sub> values. As a result, a once daily dose of 14 mg with a <i>C</i><sub>max</sub> of 70 ng/mL (165 nM; 13.7 nM free) and an AUC of 1403 ng·h/mL (3298 nM·h/mL; 273 nM·h/mL free) was projected to maintain <i>C</i><sub>trough</sub> at the EC<sub>80</sub> (achieving Aβ reduction of 80%), whereas a daily dose of 2.9 mg was required to maintain 50% Aβ reduction. In multiple ascending doses (MAD) of verubecestat and elenbecestat in healthy adults, once daily doses of 40 and 75 mg, respectively, were required to reduce Aβ by about 80%; atabecestat at 30 mg was needed to achieve 80% Aβ reduction in the MAD study,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> implying that <b>5</b> could be used at a reduced human daily dosage relative to the clinical compounds as well as to achieve around 10 mg/day even with approximate maximum Aβ reduction. Having established a high in vivo potency and a low projected human dosage, the development of <b>5</b> progressed to in vivo cardiovascular safety and 2-week exploratory toxicology studies.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Profiles of <b>5</b> in Preclinical Species<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">mouse</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">dog</th><th class="colsep0 rowsep0" align="center" char=".">monkey</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center">dose (iv): 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>dss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">13.7</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center">dose (po): 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="char" char=".">195</td><td class="colsep0 rowsep0" align="char" char=".">148</td><td class="colsep0 rowsep0" align="char" char=".">685</td><td class="colsep0 rowsep0" align="char" char=".">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (ng·h/mL)</td><td class="colsep0 rowsep0" align="char" char=".">596</td><td class="colsep0 rowsep0" align="char" char=".">566</td><td class="colsep0 rowsep0" align="char" char=".">10,366</td><td class="colsep0 rowsep0" align="char" char=".">429</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Dosed as a solution of <b>5</b> in 20% HPBCD.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cardiovascular Safety</h3><div class="NLM_p last">The cardiovascular safety of <b>5</b> was evaluated with guinea pig and dog.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> To anesthetized guinea pigs (<i>n</i> = 7), <b>5</b> was administered intravenously at doses of 0.19, 0.38, 0.75, 1.5, 3, and 6 mg/kg over a period of 5 at 15 min intervals. Compound <b>5</b> had no statistically significant effects on QTcB intervals compared to the vehicle, where the no observed adverse effect level (NOAEL) was measured to be more than 6.9 μg/mL (2.4 μM free) with a safety margin of more than 175-fold over the human projected unbound <i>C</i><sub>max</sub> sustaining Aβ reduction by 80% at trough level. In anesthetized dogs, increasing intravenous doses of 0.08, 0.16, 0.32, 0.63, 1.25, and 2.5 mg/kg were infused over 5 at 30 min intervals. Similar to the study with guinea pigs, <b>5</b> did not show QTc prolongation or other physiologically relevant effects. Based on the NOAEL of more than 6.9 μg/mL (1.3 μM free), the safety margin was calculated to be more than 95-fold. These results demonstrated the excellent cardiovascular safety of compound <b>5</b>.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Toxicology</h3><div class="NLM_p last">Prior to the 2-week tolerance study, a single ascending dose study was carried out with rat (0, 100, 500, and 2000 mg/kg; <i>n</i> = 5) and dog (0, 25, 50, and 100 mg/kg; <i>n</i> = 2), in which adverse events such as central nervous system (CNS) symptoms and body weight loss were observed at the highest doses for both rats and dogs. Sprague-Dawley rats (<i>n</i> = 10) were given oral doses of 0, 100, 250, and 500 mg/kg/day as a suspension of 0.5% methylcellulose for a period of 2 weeks. With the 500 mg/kg/day dose, reduced body weight and food consumption as well as stomach necrosis were considered toxicologically relevant, and the medium dose of 250 mg/kg/day was considered the NOAEL (AUC = 68 μg·h/mL) with a safety margin of 49-fold over the projected human AUC achieving sustained 80% Aβ reduction. Beagle dogs (<i>n</i> = 4) were given oral doses of 6, 20, and 50 mg/kg/day using the same formulation protocol for a period of 2 weeks. At 50 mg/kg/day, CNS symptoms, such as convulsions, tremors, twitching, vomiting, and salivation, were pronounced; at 20 mg/kg/day, tremors were observed. On the basis of these results, the NOAEL was considered to be 6 mg/kg/day (AUC = 41 μg·h/mL) with a safety margin of 29-fold over the human projected AUC. Importantly, no clinical or histopathological findings derived from liver toxicity were observed in the 2-week tolerance study of <b>5</b>, whereas the toxicity study for the same period of atabecestat at the highest dose showed indications of liver toxicity such as alanine aminotransferase elevation and inflammatory cell infiltration of centrilobular hepatocytes. With respect to <b>5</b>, the lower liver toxicity as well as the excellent cardiovascular safety profiles supported its advancement to Investigational New Drug (IND) enabling studies. Unfortunately, in a 1-month GLP toxicity study with rat, administration of <b>5</b> led to a rare phospholipidosis (PLD) in the brain at the highest dose, resulting in neuronal cell death. This significant finding suspended further evaluation of compound <b>5</b>. A 1,4-oxazine-based BACE1 inhibitor exhibited PLD in the peripheral tissues in a 1-month rat toxicology study, although it was found to be reversible.<a onclick="showRef(event, 'ref16 cit16a'); return false;" href="javascript:void(0);" class="ref ref16 cit16a">(16a)</a> PLD is related to lipophilicity for basic compounds, and cationic amphiphilic compounds with cLogP > 3 and p<i>K</i><sub>a</sub> > 8 generally cause PLD. Given its acceptable physicochemical profile (Log <i>D</i> = 2.4 and p<i>K</i><sub>a</sub> = 7.3), it was unclear why <b>5</b> exhibited PLD.<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A p<i>K</i><sub>a</sub> lowering strategy based on an oxazine lead <b>1</b> led to the discovery of thiazine <b>5</b> with increased cellular potency retaining other favorable properties observed in <b>1</b>, such as hERG inhibitory activity and P-gp efflux. The improved cellular potency reflected robust Aβ reduction in vivo at low concentrations, leading to a low human projected dose of 14 mg/day to achieve Aβ reduction of 80% at trough level. Compound <b>5</b> offered sufficient safety margins in the preclinical cardiovascular safety models. A difference in liver toxicity profile between <b>5</b> and atabecestat was noted in the 2-week tolerance study in dog, where <b>5</b> showed no significant adverse events related to liver toxicity compared to atabecestat, which led to <b>5</b> being considered as a suitable backup candidate for atabecestat. However, further work on <b>5</b> was stopped due to unexpected phospholipidosis in the brain during its IND enabling study.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Chemistry</h3><div class="NLM_p last">All commercial reagents and solvents were used as received unless otherwise noted. Flash column chromatography was carried out with an automated purification system using Yamazen or Fuji Silysia prepacked silica gel columns. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded with a Bruker Advance 400 and 100 MHz spectrometers, respectively. Analytical LC/MS was performed with a Shimadzu Shim-pack XR-ODS (C18, 2.2 μm, 3.0 × 50 mm, a linear gradient from 10% to 100% B over 3 min and then 100% B for 1 min (A = H<sub>2</sub>O + 0.1% formic acid, B = MeCN + 0.1% formic acid), flow rate 1.6 mL/min) using a Shimadzu UFLC system equipped with a LCMS-2020 mass spectrometer, LC-20AD binary gradient module, SPD-M20A photodiode array detector (detection at 254 nm), and SIL-20AC sample manager. The purity of all compounds used in the bioassays was determined by this method to be >95%. High resolution mass spectra were recorded with a Thermo Fisher Scientific LTQ Orbitrap using electrospray positive ionization.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>N</i>-(3-((4<i>R</i>,5<i>R</i>,6<i>R</i>)-2-Amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide (<b>5</b>)</h3><div class="NLM_p last">To a solution of <b>11</b> (3.40 g, 13.3 mmol) in TFA (32.0 mL) was added sulfuric acid (8.00 mL) dropwise at −20 °C and then fuming HNO<sub>3</sub> (0.593 mL, 13.3 mmol). After stirring for 1 h at −20 °C, the mixture was poured into aqueous K<sub>2</sub>CO<sub>3</sub> solution at 0 °C. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give the crude compound (4.43 g) as a tan amorphous substance. To a solution of this crude compound (4.43 g) in toluene (40.0 mL) and H<sub>2</sub>O (40.0 mL) were added Fe (6.24 g, 112 mmol) and NH<sub>4</sub>Cl (8.97 g, 168 mmol). The reaction mixture was heated to 80 °C for 1.5 h and then cooled to room temperature. The mixture was diluted with aqueous K<sub>2</sub>CO<sub>3</sub> solution and filtered through Celite. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over MgSO4, and concentrated to give crude compound (3.36 g) as a tan solid. To a solution of this crude compound (332 mg), 5-(fluoromethoxy)pyrazine-2-carboxylic acid (211 mg, 1.22 mmol), and HCl in water (2 mol/L in water; 612 μL, 1.22 mmol) in MeOH was added 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride (EDC·HCl) (258 mg, 1.35 mmol) at 0 °C. The mixture was stirred at room temperature for 1 h and then quenched with aqueous NaHCO<sub>3</sub> solution. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude compound was crystallized with acetone/H<sub>2</sub>O (1:3) to give <b>5</b> (484 mg, 91% over 3 steps) as a white solid. The stereochemistry was confirmed by <sup>19</sup>F–<sup>1</sup>H HOESY and a cocrystal structure of <b>5</b> bound to BACE (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01140/suppl_file/jm9b01140_si_001.pdf" class="ext-link">Figure S5</a>; see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01140/suppl_file/jm9b01140_si_001.pdf" class="ext-link">Supporting Information</a>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.47 (1H, br s), 9.08 (1H, d, <i>J</i> = 1.1 Hz), 8.30 (1H, d, <i>J</i> = 1.1 Hz), 7.99 (1H, ddd, <i>J</i> = 8.9, 4.0, 2.8 Hz), 7.29 (1H, dd, <i>J</i> = 6.8, 2.8 Hz), 7.09 (1H, dd, <i>J</i> = 11.5, 8.9 Hz), 6.15 (2H, ddd, <i>J</i> = 51.1, 4.5, 2.0 Hz), 5.12 (1H, dd, <i>J</i> = 47.6, 1.4 Hz), 3.16–3.03 (1H, m), 1.77 (3H, s), 1.34 (3H, d, <i>J</i> = 6.9 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 160.4, 159.3 (d, <i>J</i> = 2.5 Hz), 155.6 (d, <i>J</i> = 243.8 Hz), 152.0, 141.8, 139.6, 133.9 (d, <i>J</i> = 2.4 Hz), 133.2, 131.9 (dd, <i>J</i> = 14.4, 6.4 Hz), 120.7 (d, <i>J</i> = 8.6 Hz), 120.5 (br-d, <i>J</i> = 3.1 Hz), 117.2 (d, <i>J</i> = 25.7 Hz), 95.8 (d, <i>J</i> = 223.6 Hz), 86.5 (dd, <i>J</i> = 185.7, 7.3 Hz), 62.04 (dd, <i>J</i> = 21.1, 5.2 Hz), 36.0 (d, <i>J</i> = 20.8 Hz), 26.5 (t, <i>J</i> = 4.0 Hz), 17.7 (d, <i>J</i> = 2.4 Hz). HRMS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for [C<sub>18</sub>H<sub>19</sub>O<sub>2</sub>N<sub>5</sub>F<sub>3</sub>S]<sup>+</sup> 426.1206, found 426.1201.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>tert</i>-Butyl ((2<i>R</i>,3<i>S</i>)-3-Fluoro-2-(2-fluorophenyl)pent-4-en-2-yl)carbamate (<b>7</b>)</h3><div class="NLM_p last">To a solution of <b>6</b> (18.8 g, 54.8 mmol) in DCM (190 mL) was added a solution of DIBAL (1.02 mol/L in hexane; 177 mL, 181 mmol) at −78 °C. The resulting solution was stirred at −78 °C for 2.5 h. The reaction mixture was poured into an aqueous Rochelle’s solution and extracted with DCM. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give the crude compound (16.5 g) as a yellow oil. To a solution of methyltriphenylphosphonium bromide (48.9 g, 137 mmol) in toluene (250 mL) was added KO<i>t</i>-Bu (1.0 M, in THF; 126 mL, 126 mmol) at room temperature. The mixture was stirred at room temperature for 1 h, and then a solution of the crude compound in toluene (50.0 mL) was added at 0 °C. The resulting mixture was stirred at room temperature overnight and then quenched with aqueous NH<sub>4</sub>Cl solution. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude compound was purified by silica gel column chromatography eluting with 5–20% EtOAc in hexane to provide compound <b>7</b> (6.35 g, 21.4 mmol, 39% in 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36 (1H, t, J = 8.0 Hz), 7.28–7.24 (1H, m), 7.12 (1H, td, <i>J</i> = 7.8, 1.4 Hz), 7.02 (1H, dd, <i>J</i> = 12.7, 8.2 Hz), 5.74–5.62 (1H, m), 5.47–5.30 (3H, m), 5.17 (1H, br s), 1.86 (3H, s), 1.38 (9H, s).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>N</i>-(((2<i>R</i>,3<i>S</i>)-3-Fluoro-2-(2-fluorophenyl)pent-4-en-2-yl)carbamothioyl)benzamide (<b>8</b>)</h3><div class="NLM_p last">To a solution of <b>7</b> (6.35 g, 21.4 mmol) in DCM (40.0 mL) was added 4 mol/L of HCl in dioxane (26.7 mL, 107 mmol) at room temperature, and the mixture was stirred for 1 h. The mixture was poured into aqueous NaHCO<sub>3</sub> solution. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give the crude compound (4.74 g) as a tan liquid. To a solution of this crude compound in DCM (40 mL) was added benzoyl isothiocyanate (3.16 mL, 23.5 mmol) at 0 °C. The resulting mixture was warmed to room temperature and stirred overnight. The reaction solution was concentrated, and the residue was purified by silica gel column chromatography using 5–20% EtOAc in hexane to provide compound <b>8</b> (7.29 g, 20.2 mmol, 95% in 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.51 (1H, s), 8.83 (1H, s), 7.85 (2H, d, J = 7.4 Hz), 7.63 (1H, t, <i>J</i> = 7.4 Hz), 7.52 (2H, t, <i>J</i> = 7.7 Hz), 7.44 (1H, t, <i>J</i> = 8.0 Hz), 7.33–7.27 (1H, m), 7.16 (1H, td, <i>J</i> = 7.8, 1.0 Hz), 7.04 (1H, ddd, <i>J</i> = 12.5, 8.2, 1.0 Hz), 5.95–5.83 (1H, m), 5.69 (1H, dd, <i>J</i> = 46.4, 6.1 Hz), 5.66–5.62 (1H, m), 5.49 (1H, d, <i>J</i> = 10.9 Hz), 2.13 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 361 [M + H]<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-((4<i>R</i>,5<i>R</i>,6<i>S</i>)-5-Fluoro-4-(2-fluorophenyl)-6-(iodomethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)benzamide (<b>9</b>)</h3><div class="NLM_p last">To a solution of <b>8</b> (7.29 g, 20.2 mmol) in MeCN (80 mL) was added iodine (10.3 g, 40.5 mmol) at 0 °C. After stirring for 1 h, the mixture was diluted with aqueous NaHCO<sub>3</sub> solution and aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude compound was purified by silica gel column chromatography eluting with 5–20% EtOAc in hexane to provide compound <b>9</b> (8.04 g, 16.5 mmol, 82%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.67 (1H, br s), 8.21 (2H, d, <i>J</i> = 7.4 Hz), 7.53 (1H, t, J = 7.3 Hz), 7.45 (2H, t, <i>J</i> = 7.5 Hz), 7.41–7.36 (1H, m), 7.34 (1H, t, <i>J</i> = 7.8 Hz), 7.20 (1H, t, <i>J</i> = 8.0 Hz), 7.15 (1H, dd, <i>J</i> = 12.2, 8.2 Hz), 5.70 (1H, d, <i>J</i> = 47.7 Hz), 3.53–3.48 (1H, m), 3.27–3.15 (2H, m), 1.90 (3H, s). MS-ESI (<i>m</i>/<i>z</i>): 487 [M + H]<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-((4<i>R</i>,5<i>R</i>,6<i>R</i>)-5-Fluoro-4-(2-fluorophenyl)-4,6-dimethyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl)benzamide (<b>10</b>)</h3><div class="NLM_p last">To a solution of <b>9</b> (8.04 g, 16.5 mmol) in toluene (80 mL) were added Bu<sub>3</sub>SnH (6.62 mL, 24.8 mmol) and AIBN (0.136 g, 0.827 mmol). The solution was heated to 80 °C for 2 h and then cooled to room temperature. The mixture was concentrated, and the residue was purified by silica gel column chromatography eluting with 5–20% EtOAc in hexane to provide compound <b>10</b> (5.35 g, 14.8 mmol, 90%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.07 (1H, br s), 8.23 (2H, d, <i>J</i> = 7.5 Hz), 7.51 (1H, t, <i>J</i> = 7.3 Hz), 7.44 (2H, t, <i>J</i> = 7.5 Hz), 7.40–7.34 (2H, m), 7.20 (1H, t, <i>J</i> = 7.6 Hz), 7.11 (1H, dd, <i>J</i> = 12.2, 8.2 Hz), 5.26 (1H, d, <i>J</i> = 46.9 Hz), 3.13 (1H, dq, <i>J</i> = 31.3, 6.9 Hz), 1.87 (3H, s), 1.41 (3H, d, <i>J</i> = 6.9 Hz). MS-ESI (<i>m</i>/<i>z</i>): 361 [M + H]<sup>+</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (4<i>R</i>,5<i>R</i>,6<i>R</i>)-5-Fluoro-4-(2-fluorophenyl)-4,6-dimethyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>11</b>)</h3><div class="NLM_p last">To a solution of <b>10</b> (5.35 g, 14.8 mmol) in EtOH (50.0 mL) was added hydrazine monohydrate (3.60 mL, 74.2 mmol) at room temperature. After stirring overnight, the reaction mixture was concentrated. The resulting residue was purified by silica gel column chromatography eluting with 20–70% EtOAc in hexane to provide compound <b>11</b> (3.45 g, 13.5 mmol, 91%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30–7.24 (2H, m), 7.12 (1H, t, <i>J</i> = 7.5 Hz), 7.03 (1H, dd, <i>J</i> = 12.0, 8.3 Hz), 5.09 (1H, d, <i>J</i> = 47.7 Hz), 4.55 (2H, br s), 3.02 (1H, dq, <i>J</i> = 31.1, 6.8 Hz), 1.74 (3H, s), 1.32 (3H, d, <i>J</i> = 6.8 Hz). MS-ESI (<i>m</i>/<i>z</i>): 257 [M + H]<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Biochemical BACE1 Assay</h3><div class="NLM_p last">The biochemical BACE1 IC<sub>50</sub> values were determined by an HTRF assay using an APP derived peptide as described previously.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Cellular Aβ Assay</h3><div class="NLM_p last">The cellular Aβ IC<sub>50</sub> values were determined by measuring Aβ40 using a HTRF assay in SH-SY5Y cells expressing human APP as described previously.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> In Vitro ADMET Assays</h3><div class="NLM_p last">Metabolic stability in microsomes, P-gp efflux ratio, solubility, protein binding, brain tissue binding, CYP IC<sub>50</sub>, and hERG inhibitory activity were determined according to procedures described previously.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> In Vivo Experiments</h3><div class="NLM_p last">In vivo experimental studies were performed at Janssen and Shionogi. All the procedures were in accordance with regulations and established guidelines and were approved by the local ethical committees of both companies: the Ethical Committee on Laboratory Animal Testing (ECD, Janssen Beerse) and the Shionogi Animal Care and Use Committee.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> In Vivo Pharmacokinetic Study</h3><div class="NLM_p last">The test compound was dissolved in 20% HPBCD, and the detailed method was described previously.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Mouse PK/PD Study</h3><div class="NLM_p last">The test compound was dissolved in 20% HPBCD and was orally administered to male Crl:CD1 (ICR) mice (6 to 8 weeks old; <i>n</i> = 4) at 1 and 3 mg/kg doses. The total Aβ levels were measured using an ELISA method, and the details of which were described previously.<a onclick="showRef(event, 'cit11a cit11b'); return false;" href="javascript:void(0);" class="ref cit11a cit11b">(11a,b)</a></div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Dog PK/PD Study</h3><div class="NLM_p last">The effect of the compounds on the Aβ profile in CSF of beagle dogs was tested in combination with PK follow-up. The lowering effect was described as EC<sub>50</sub> and EC<sub>80</sub> values, which are defined as the plasma level of a tested compound required for 50% and 90% lowering of Aβ in CSF. These values were determined after testing of the compound for dose response, using the statistical methods. The detailed method was described previously.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> In Vivo Toxicology Study in Rat</h3><div class="NLM_p last">A single-dose oral toxicity study was conducted with male Sprague-Dawley rats (<i>n</i> = 5 per group). The test compound was administered at 0, 100, 500, or 2,000 mg/kg (dose volume = 10 mL/kg) and was formulated as an aqueous suspension containing 0.5% (w/v) methylcellulose. A 2-week repeated-dose oral toxicity study with the test compound was conducted with male Sprague-Dawley rats (<i>n</i> = 5 per main group) at 0, 100, 250, and 500 mg/kg/day as an aqueous suspension in 0.5% (w/v) methylcellulose. For toxicokinetic purposes, an additional 3 rats per test compound-treated group were included. Toxicokinetic parameters of <b>5</b> in rat and dog are given in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01140/suppl_file/jm9b01140_si_001.pdf" class="ext-link">Tables S1–S5</a> (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01140/suppl_file/jm9b01140_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> In Vivo Toxicology Study in Dog</h3><div class="NLM_p last">A single-dose oral toxicity study was conducted with female beagle dogs (<i>n</i> = 2 per group). A dose of 100 mg/kg was administered as a nonclear aqueous solution containing 25% w/v HPBCD (HCl to pH 2; dose volume = 5 mL/kg) or as a suspension in 0.5% (w/v) methylcellulose aq. (dose volume = 2 mL/kg). A 2-week repeated-dose oral toxicity study was conducted with male and female beagle dogs (<i>n</i> = 2 per group) at 6, 20, and 60 mg/kg/day as a suspension in 0.5% (w/v) methylcellulose aq. For toxicokinetic purposes, the same dogs as for the test compound-treated group were used.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01140" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01140" class="ext-link">10.1021/acs.jmedchem.9b01140</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Toxicokinetic parameters of <b>5</b> in rat and dog, experimental procedures for in vivo cardiovascular safety study, human dose and PK projections, <sup>1</sup>H NMR, <sup>13</sup>C NMR, <sup>19</sup>F–<sup>1</sup>H HOESY data for <b>5</b>, and crystallographic data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01140/suppl_file/jm9b01140_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES strings, BACE1 IC<sub>50</sub>, and cellular Aβ<sub>40</sub> IC<sub>50</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01140/suppl_file/jm9b01140_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01140/suppl_file/jm9b01140_si_001.pdf">jm9b01140_si_001.pdf (1.44 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01140/suppl_file/jm9b01140_si_002.csv">jm9b01140_si_002.csv (0.42 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB accession code for the X-ray structure of <b>5</b> bound to human BACE1 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JT3">6JT3</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b01140" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18264" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18264" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ken-ichi Kusakabe</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9055-8267" title="Orcid link">http://orcid.org/0000-0001-9055-8267</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8ae1efe4a7e3e9e2e3a4e1fff9ebe1ebe8efcaf9e2e3e5e4e5ede3a4e9e5a4e0fa"><span class="__cf_email__" data-cfemail="8ee5ebe0a3e7ede6e7a0e5fbfdefe5efecebcefde6e7e1e0e1e9e7a0ede1a0e4fe">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Genta Tadano</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazuo Komano</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuhei Yoshida</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shinji Suzuki</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenji Nakahara</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kouki Fuchino</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazuki Fujimoto</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eriko Matsuoka</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takahiko Yamamoto</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span>; 
    <span>Present Address:
                        API Process Development Department (Biotechnology), Pharmaceutical Technology Division, Chugai Pharmaceutical Co., Ltd., 5-1, Ukima 5-chome, Kita-ku, Tokyo 115-8543, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naoya Asada</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hisanori Ito</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gaku Sakaguchi</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naoki Kanegawa</span> - <span class="hlFld-Affiliation affiliation">Research Laboratory
for Development and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasuto Kido</span> - <span class="hlFld-Affiliation affiliation">Research Laboratory
for Development and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shigeru Ando</span> - <span class="hlFld-Affiliation affiliation">Research Laboratory
for Development and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tamio Fukushima</span> - <span class="hlFld-Affiliation affiliation">Research Laboratory
for Development and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ard Teisman</span> - <span class="hlFld-Affiliation affiliation">Non-Clinical Safety and , Janssen
Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vijay Urmaliya</span> - <span class="hlFld-Affiliation affiliation">Non-Clinical Safety and , Janssen
Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah Dhuyvetter</span> - <span class="hlFld-Affiliation affiliation">Non-Clinical Safety and , Janssen
Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herman Borghys</span> - <span class="hlFld-Affiliation affiliation">Non-Clinical Safety and , Janssen
Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">An Van Den Bergh</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences and , Janssen
Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nigel Austin</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences and , Janssen
Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</span>; 
    <span>Present Address:
                        Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, UK</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harrie J. M. Gijsen</span> - <span class="hlFld-Affiliation affiliation">Discovery Sciences and , Janssen
Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8020-4828" title="Orcid link">http://orcid.org/0000-0001-8020-4828</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshinori Yamano</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasuyoshi Iso</span> - <span class="hlFld-Affiliation affiliation">Discovery
Research Laboratory for Core Therapeutic Areas and , Shionogi Pharmaceutical
Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73145" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73145" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Maki Hattori, Masanori Nakae, and Maito Douma for the biological assays, Yumiko Takagi for the elemental analysis, Yuki Aoe for the HRMS analysis, and Yukiko Kan for the NMR analysis. We gratefully thank the members of the Janssen-Shionogi research collaboration for the support of this program. We are grateful to Judy Noguchi for proofreading the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid-β</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-site amyloid precursor protein cleaving enzyme 1</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">DIBAL</td><td class="NLM_def"><p class="first last">diisobutylaluminum hydride</p></td></tr><tr><td class="NLM_term">EDC·HCl</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">HPBCD</td><td class="NLM_def"><p class="first last">hydroxypropyl-β-cyclodextrin</p></td></tr><tr><td class="NLM_term">IND</td><td class="NLM_def"><p class="first last">Investigational New Drug</p></td></tr><tr><td class="NLM_term">MAD</td><td class="NLM_def"><p class="first last">multiple ascending dose</p></td></tr><tr><td class="NLM_term">NOAEL</td><td class="NLM_def"><p class="first last">no observed adverse effect level</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamic</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PLD</td><td class="NLM_def"><p class="first last">phospholipidosis</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 16 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, M.</span>; <span class="NLM_string-name">Comas-Herrera, A.</span>; <span class="NLM_string-name">Knapp, M.</span>; <span class="NLM_string-name">Guerchet, M.</span>; <span class="NLM_string-name">Karagiannidou, M.</span></span> <span> </span><span class="NLM_article-title">World Alzheimer Report 2016</span>. <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf" class="extLink">https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf</a> (accessed February 20, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Prince&author=A.+Comas-Herrera&author=M.+Knapp&author=M.+Guerchet&author=M.+Karagiannidou&title=World+Alzheimer+Report+2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26atitle%3DWorld%2520Alzheimer%2520Report%25202016%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease at 25 years</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.15252/emmm.201606210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.15252%2Femmm.201606210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=27025652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=595-608&author=D.+J.+Selkoeauthor=J.+Hardy&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease+at+25+years&doi=10.15252%2Femmm.201606210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease at 25 years</span></div><div class="casAuthors">Selkoe, Dennis J.; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">595-608</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Despite continuing debate about the amyloid β-protein or Aβ hypothesis, new lines of evidence from labs. and clinics worldwide support the concept that an imbalance between prodn. and clearance of Aβ42 and related Aβ peptides is a very early, often initiating factor in Alzheimer's disease AD.  Confirmation that presenilin is the catalytic site of γ-secretase has provided a linchpin: all dominant mutations causing early-onset AD occur either in the substrate amyloid precursor protein, APP or the protease presenilin of the reaction that generates Aβ.  Duplication of the wild-type APP gene in Down's syndrome leads to Aβ deposits in the teens, followed by microgliosis, astrocytosis, and neurofibrillary tangles typical of AD.  Apolipoprotein E4, which predisposes to AD in > 40% of cases, has been found to impair Aβ clearance from the brain.  Sol. oligomers of Aβ42 isolated from AD patients' brains can decrease synapse no., inhibit long-term potentiation, and enhance long-term synaptic depression in rodent hippocampus, and injecting them into healthy rats impairs memory.  The human oligomers also induce hyperphosphorylation of tau at AD-relevant epitopes and cause neuritic dystrophy in cultured neurons.  Crossing human APP with human tau transgenic mice enhances tau-pos. neurotoxicity.  In humans, new studies show that low cerebrospinal fluid CSF Aβ42 and amyloid-PET positivity precede other AD manifestations by many years.  Most importantly, recent trials of three different Aβ antibodies solanezumab, crenezumab, and aducanumab have suggested a slowing of cognitive decline in post hoc analyses of mild AD subjects.  Although many factors contribute to AD pathogenesis, Aβ dyshomeostasis has emerged as the most extensively validated and compelling therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGo1qmyvVtbVg90H21EOLACvtfcHk0li7j0Qk1urKBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D&md5=b7a2003ba5d341f5eef5c7e9454235ce</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.15252%2Femmm.201606210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201606210%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520at%252025%2520years%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D595%26epage%3D608%26doi%3D10.15252%2Femmm.201606210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaedal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulem, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudbjartsson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhangale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenlocher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsdottir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreassen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jönsson, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palotie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsteinsdottir, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, K.</span></span> <span> </span><span class="NLM_article-title">A mutation in APPprotects against Alzheimer’s disease and age-related cognitive decline</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APPprotects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0ljoke3B5nKaHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APPprotects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the β secretase BACE1 for Alzheimer’s disease therapy</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(13)70276-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1016%2FS1474-4422%2813%2970276-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=24556009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=319-329&author=R.+Yanauthor=R.+Vassar&title=Targeting+the+%CE%B2+secretase+BACE1+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1016%2FS1474-4422%2813%2970276-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the β secretase BACE1 for Alzheimer's disease therapy</span></div><div class="casAuthors">Yan, Riqiang; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-329</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The β secretase, widely known as β-site amyloid precursor protein cleaving enzyme 1 (BACE1), initiates the prodn. of the toxic amyloid β (Aβ) that plays a crucial early part in Alzheimer's disease pathogenesis.  BACE1 is a prime therapeutic target for lowering cerebral Aβ concns. in Alzheimer's disease, and clin. development of BACE1 inhibitors is being intensely pursued.  Although BACE1 inhibitor drug development has proven challenging, several promising BACE1 inhibitors have recently entered human clin. trials.  The safety and efficacy of these drugs are being tested at present in healthy individuals and patients with Alzheimer's disease, and will soon be tested in individuals with presymptomatic Alzheimer's disease.  Although hopes are high that BACE1 inhibitors might be efficacious for the prevention or treatment of Alzheimer's disease, concerns have been raised about potential mechanism-based side-effects of these drugs.  The potential of therapeutic BACE1 inhibition might prove to be a watershed in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8SsSfCAC6nbVg90H21EOLACvtfcHk0ljoke3B5nKaHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D&md5=11aeb06fee19cafc0b361e2c43900806</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970276-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970276-X%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520%25CE%25B2%2520secretase%2520BACE1%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D319%26epage%3D329%26doi%3D10.1016%2FS1474-4422%2813%2970276-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Theevolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=Theevolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0ljoke3B5nKaHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DTheevolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A.</span>; <span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Targeting β-secretase (BACE) for the treatment of Alzheimer’s disease</span>. In  <i>Comprehensive Medicinal Chemistry III</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>, <span class="NLM_string-name">Rotella, D. P.</span>, <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">7</span>, pp  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">383</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1016%2FB978-0-12-409547-2.13809-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=326-383&author=A.+Hall&author=H.+J.+M.+Gijsenauthor=S.+Chackalamannil&author=D.+P.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DA.%26atitle%3DTargeting%2520%25CE%25B2-secretase%2520%2528BACE%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26volume%3D7%26spage%3D326%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">761</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.12.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1016%2Fj.bmcl.2018.12.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=30709653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=761&author=C.-C.+Hsiaoauthor=F.+Romboutsauthor=H.+J.+M.+Gijsen&title=New+evolutions+in+the+BACE1+inhibitor+field+from+2014+to+2018&doi=10.1016%2Fj.bmcl.2018.12.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span></div><div class="casAuthors">Hsiao, Chien-Chi; Rombouts, Frederik; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">761-777</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors offer the potential of disease-modifying treatment for Alzheimer's disease (AD).  Since 2014, major breakthroughs have appeared in the field of BACE1 inhibitors.  This review provides an overview of amidine-based BACE1 inhibitors between 2014 and 2018.  Herein are summarized (i) the structure-activity relationship, (ii) the physiol. results and (iii) the potential risks from a lack of selectivity.  This review also summarizes clin. scope, results and outlook of the compds. that have been or are currently under development in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3OfI_B-BJ-LVg90H21EOLACvtfcHk0ljnFwTP_LI3NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D&md5=049eda6ce97b31a04b5b579afd3e11e5</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DC.-C.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DNew%2520evolutions%2520in%2520the%2520BACE1%2520inhibitor%2520field%2520from%25202014%2520to%25202018%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D761%26doi%3D10.1016%2Fj.bmcl.2018.12.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)-A β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29-A+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0ljnFwTP_LI3NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529-A%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furtek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahoney, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozley, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberghe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelson, D.</span></span> <span> </span><span class="NLM_article-title">Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1706441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1056%2FNEJMoa1706441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=29719179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsFyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2018&pages=1691-1703&author=M.+F.+Eganauthor=J.+Kostauthor=P.+N.+Tariotauthor=P.+S.+Aisenauthor=J.+L.+Cummingsauthor=B.+Vellasauthor=C.+Surauthor=Y.+Mukaiauthor=T.+Vossauthor=C.+Furtekauthor=E.+Mahoneyauthor=L.+H.+Mozleyauthor=R.+Vandenbergheauthor=Y.+Moauthor=D.+Michelson&title=Randomized+trial+of+verubecestat+for+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1706441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Egan, Michael F.; Kost, James; Tariot, Pierre N.; Aisen, Paul S.; Cummings, Jeffrey L.; Vellas, Bruno; Sur, Cyrille; Mukai, Yuki; Voss, Tiffini; Furtek, Christine; Mahoney, Erin; Mozley, Lyn Harper; Vandenberghe, Rik; Mo, Yi; Michelson, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1691-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease is characterized by the deposition of amyloid-beta (Aβ) plaques in the brain.  Aβ is produced from the sequential cleavage of amyloid precursor protein by β-site amyloid precursor protein-cleaving enzyme 1 (BACE-1) followed by γ-secretase.  Verubecestat is an oral BACE-1 inhibitor that reduces the Aβ level in the cerebrospinal fluid of patients with Alzheimer's disease.  Methods: We conducted a randomized, double-blind, placebo-controlled, 78-wk trial to evaluate verubecestat at doses of 12 mg and 40 mg per day, as compared with placebo, in patients who had a clin. diagnosis of mild-to-moderate Alzheimer's disease.  The coprimary outcomes were the change from baseline to week 78 in the score on the cognitive subscale of the Alzheimer's disease Assessment Scale (ADAS-cog; scores range from 0 to 70, with higher scores indicating worse dementia) and in the score on the Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory scale (ADCS-ADL; scores range from 0 to 78, with lower scores indicating worse function).  Results: A total of 1958 patients underwent randomization; 653 were randomly assigned to receive verubecestat at a dose of 12 mg per day (the 12-mg group), 652 to receive verubecestat at a dose of 40 mg per day (the 40-mg group), and 653 to receive matching placebo.  The trial was terminated early for futility 50 mo after onset, which was within 5 mo before its scheduled completion, and after enrollment of the planned 1958 patients was complete.  The estd. mean change from baseline to week 78 in the ADAS-cog score was 7.9 in the 12-mg group, 8.0 in the 40-mg group, and 7.7 in the placebo group (P = 0.63 for the comparison between the 12-mg group and the placebo group and P = 0.46 for the comparison between the 40-mg group and the placebo group).  The estd. mean change from baseline to week 78 in the ADCS-ADL score was -8.4 in the 12-mg group, -8.2 in the 40-mg group, and -8.9 in the placebo group (P = 0.49 for the comparison between the 12-mg group and the placebo group and P = 0.32 for the comparison between the 40-mg group and the placebo group).  Adverse events, including rash, falls and injuries, sleep disturbance, suicidal ideation, wt. loss, and hair-color change, were more common in the verubecestat groups than in the placebo group. conclusions Verubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate Alzheimer's disease and was assocd. with treatment-related adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroW5Tf-VIj2LVg90H21EOLACvtfcHk0lh3KnTzV4k2SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsFyqsbs%253D&md5=e6ecfbd2981616b343468ae8bed1db2d</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1706441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1706441%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DM.%2BF.%26aulast%3DKost%26aufirst%3DJ.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DMukai%26aufirst%3DY.%26aulast%3DVoss%26aufirst%3DT.%26aulast%3DFurtek%26aufirst%3DC.%26aulast%3DMahoney%26aufirst%3DE.%26aulast%3DMozley%26aufirst%3DL.%2BH.%26aulast%3DVandenberghe%26aufirst%3DR.%26aulast%3DMo%26aufirst%3DY.%26aulast%3DMichelson%26aufirst%3DD.%26atitle%3DRandomized%2520trial%2520of%2520verubecestat%2520for%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2018%26volume%3D378%26spage%3D1691%26epage%3D1703%26doi%3D10.1056%2FNEJMoa1706441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Merck &
Co., Inc</span>. <a href="https://investors.merck.com/news/press-release-details/2018/Merck-Announces-Discontinuation-of-APECS-Study-Evaluating-Verubecestat-MK-8931-for-the-Treatment-of-People-with-Prodromal-Alzheimers-Disease/default.aspx" class="extLink">https://investors.merck.com/news/press-release-details/2018/Merck-Announces-Discontinuation-of-APECS-Study-Evaluating-Verubecestat-MK-8931-for-the-Treatment-of-People-with-Prodromal-Alzheimers-Disease/default.aspx</a> (accessed January 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Merck+%26%0ACo.%2C+Inc.+https%3A%2F%2Finvestors.merck.com%2Fnews%2Fpress-release-details%2F2018%2FMerck-Announces-Discontinuation-of-APECS-Study-Evaluating-Verubecestat-MK-8931-for-the-Treatment-of-People-with-Prodromal-Alzheimers-Disease%2Fdefault.aspx+%28accessed+January+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjaell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogstedt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P.</span></span> <span> </span><span class="NLM_article-title">AZD3293: A novel, orally active BACE1 inhibitor with high potency and permeability and markedly slow off-rate kinetics</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.3233/JAD-150834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.3233%2FJAD-150834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=26890753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVKitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=1109-1123&author=S.+Eketjaellauthor=J.+Jansonauthor=K.+Kasperssonauthor=A.+Bogstedtauthor=F.+Jeppssonauthor=J.+Faeltingauthor=S.+B.+Haeberleinauthor=A.+R.+Kuglerauthor=R.+C.+Alexanderauthor=G.+Cebersauthor=P.+Ho&title=AZD3293%3A+A+novel%2C+orally+active+BACE1+inhibitor+with+high+potency+and+permeability+and+markedly+slow+off-rate+kinetics&doi=10.3233%2FJAD-150834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics</span></div><div class="casAuthors">Eketjaell, Susanna; Janson, Juliette; Kaspersson, Karin; Bogstedt, Anna; Jeppsson, Fredrik; Faelting, Johanna; Haeberlein, Samantha Budd; Kugler, Alan R.; Alexander, Robert C.; Cebers, Gvido; Ho, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1109-1123</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A growing body of pathol., biomarker, genetic, and mechanistic data suggests that amyloid accumulation, as a result of changes in prodn., processing, and/or clearance of brain amyloid-β peptide (Aβ) concns., plays a key role in the pathogenesis of Alzheimer's disease (AD).  Beta-secretase 1 (BACE1) mediates the first step in the processing of amyloid-β protein precursor (AβPP) to Aβ peptides, with the sol. N terminal fragment of AβPP (sAβPPβ) as a direct product, and BACE1 inhibition is an attractive target for therapeutic intervention to reduce the prodn. of Aβ.  Here, we report the in vitro and in vivo pharmacol. profile of AZD3293, a potent, highly permeable, orally active, blood-brain barrier (BBB) penetrating, BACE1 inhibitor with unique slow off-rate kinetics.  The in vitro potency of AZD3293 was demonstrated in several cellular models, including primary cortical neurons.  In vivo in mice, guinea pigs, and dogs, AZD3293 displayed significant dose- and time-dependent redns. in plasma, cerebrospinal fluid, and brain concns. of Aβ40, Aβ42, and sAβPPβ.  The in vitro potency of AZD3293 in mouse and guinea pig primary cortical neuronal cells was correlated to the in vivo potency expressed as free AZD3293 concns. in mouse and guinea pig brains.  In mice and dogs, the slow off-rate from BACE1 may have translated into a prolongation of the obsd. effect beyond the turnover rate of Aβ.  The preclin. data strongly support the clin. development of AZD3293, and patients with AD are currently being recruited into a combined Phase 2/3 study to test the disease-modifying properties of AZD3293.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJMi27mSRG67Vg90H21EOLACvtfcHk0lh3KnTzV4k2SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVKitr8%253D&md5=6d022dd410874469f2fce43d463bd63c</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.3233%2FJAD-150834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-150834%26sid%3Dliteratum%253Aachs%26aulast%3DEketjaell%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKaspersson%26aufirst%3DK.%26aulast%3DBogstedt%26aufirst%3DA.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DFaelting%26aufirst%3DJ.%26aulast%3DHaeberlein%26aufirst%3DS.%2BB.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DHo%26aufirst%3DP.%26atitle%3DAZD3293%253A%2520A%2520novel%252C%2520orally%2520active%2520BACE1%2520inhibitor%2520with%2520high%2520potency%2520and%2520permeability%2520and%2520markedly%2520slow%2520off-rate%2520kinetics%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2016%26volume%3D50%26spage%3D1109%26epage%3D1123%26doi%3D10.3233%2FJAD-150834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alzforum</span>. <a href="https://www.alzforum.org/therapeutics/azd3293" class="extLink">https://www.alzforum.org/therapeutics/azd3293</a> (accessed December 23, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzforum.+https%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fazd3293+%28accessed+December+23%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alzforum</span>. <a href="http://www.alzforum.org/therapeutics/elenbecestat" class="extLink">http://www.alzforum.org/therapeutics/elenbecestat</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzforum.+http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Felenbecestat+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span>; <span class="NLM_string-name">Motoki, T.</span>; <span class="NLM_string-name">Kaneko, T.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Ishida, T.</span>; <span class="NLM_string-name">Takeda, K.</span>; <span class="NLM_string-name">Kita, Y.</span>; <span class="NLM_string-name">Yamamoto, N.</span>; <span class="NLM_string-name">Khan, A.</span>; <span class="NLM_string-name">Dimopoulos, P.</span></span> <i>Preparation of condensed aminodihydrothiazine derivatives as inhibitors of β-site APP-cleaving enzyme 1 (BACE1)</i>. WO <span class="NLM_patent">2009091016 A1</span>, July 23, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Suzuki&author=T.+Motoki&author=T.+Kaneko&author=M.+Takaishi&author=T.+Ishida&author=K.+Takeda&author=Y.+Kita&author=N.+Yamamoto&author=A.+Khan&author=P.+Dimopoulos&title=Preparation+of+condensed+aminodihydrothiazine+derivatives+as+inhibitors+of+%CE%B2-site+APP-cleaving+enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DY.%26jtitle%3DPreparation%2520of%2520condensed%2520aminodihydrothiazine%2520derivatives%2520as%2520inhibitors%2520of%2520%25CE%25B2-site%2520APP-cleaving%2520enzyme%25201%2520%2528BACE1%2529%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ufer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouzade-Dominguez, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huledal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avrameas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezous, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vormfelde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Lopez, C.</span></span> <span> </span><span class="NLM_article-title">The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer’s disease</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e9316</span> <span class="refDoi"> DOI: 10.15252/emmm.201809316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.15252%2Femmm.201809316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=30224383" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=U.+Neumannauthor=M.+Uferauthor=L.+H.+Jacobsonauthor=M.-L.+Rouzade-Dominguezauthor=G.+Huledalauthor=C.+Kollyauthor=R.+M.+Lueoendauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=K.+Hurthauthor=H.+Rueegerauthor=M.+Tintelnot-Blomleyauthor=M.+Staufenbielauthor=D.+R.+Shimshekauthor=L.+Perrotauthor=W.+Frieauffauthor=V.+Dubostauthor=H.+Schillerauthor=B.+Voggauthor=K.+Beltzauthor=A.+Avrameasauthor=S.+Kretzauthor=N.+Pezousauthor=J.+Rondeauauthor=N.+Beckmannauthor=A.+Hartmannauthor=S.+Vormfeldeauthor=O.+J.+Davidauthor=B.+Galliauthor=R.+Ramosauthor=A.+Grafauthor=C.+Lopez+Lopez&title=The+BACE-1+inhibitor+CNP520+for+prevention+trials+in+Alzheimer%E2%80%99s+disease&doi=10.15252%2Femmm.201809316"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.15252%2Femmm.201809316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201809316%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DUfer%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DRouzade-Dominguez%26aufirst%3DM.-L.%26aulast%3DHuledal%26aufirst%3DG.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DLueoend%26aufirst%3DR.%2BM.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DHurth%26aufirst%3DK.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DDubost%26aufirst%3DV.%26aulast%3DSchiller%26aufirst%3DH.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DAvrameas%26aufirst%3DA.%26aulast%3DKretz%26aufirst%3DS.%26aulast%3DPezous%26aufirst%3DN.%26aulast%3DRondeau%26aufirst%3DJ.%26aulast%3DBeckmann%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DVormfelde%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DO.%2BJ.%26aulast%3DGalli%26aufirst%3DB.%26aulast%3DRamos%26aufirst%3DR.%26aulast%3DGraf%26aufirst%3DA.%26aulast%3DLopez%2BLopez%26aufirst%3DC.%26atitle%3DThe%2520BACE-1%2520inhibitor%2520CNP520%2520for%2520prevention%2520trials%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2018%26volume%3D10%26doi%3D10.15252%2Femmm.201809316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Novartis AG</span>. <a href="https://www.globenewswire.com/news-release/2019/07/11/1881745/0/en/Novartis-Amgen-and-Banner-Alzheimer-s-Institute-discontinue-clinical-program-with-BACE-inhibitor-CNP520-for-Alzheimer-s-prevention.html" class="extLink">https://www.globenewswire.com/news-release/2019/07/11/1881745/0/en/Novartis-Amgen-and-Banner-Alzheimer-s-Institute-discontinue-clinical-program-with-BACE-inhibitor-CNP520-for-Alzheimer-s-prevention.html</a> (accessed September 1, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Novartis+AG.+https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2019%2F07%2F11%2F1881745%2F0%2Fen%2FNovartis-Amgen-and-Banner-Alzheimer-s-Institute-discontinue-clinical-program-with-BACE-inhibitor-CNP520-for-Alzheimer-s-prevention.html+%28accessed+September+1%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slemmon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Waepenaert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieltjes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelborghs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nueten, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streffer, J. R.</span></span> <span> </span><span class="NLM_article-title">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span>. <i>Alzheimers Dement (N Y)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2016.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1016%2Fj.trci.2016.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=29067308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A280%3ADC%252BC1M7kt1Wrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=202-212&author=M.+Timmersauthor=B.+Van+Broeckauthor=S.+Ramaelauthor=J.+Slemmonauthor=K.+De+Waepenaertauthor=A.+Russuauthor=J.+Bogertauthor=H.+Stieltjesauthor=L.+M.+Shawauthor=S.+Engelborghsauthor=D.+Moecharsauthor=M.+Merckenauthor=E.+Liuauthor=V.+Sinhaauthor=J.+Kempauthor=L.+Van+Nuetenauthor=L.+Tritsmansauthor=J.+R.+Streffer&title=Profiling+the+dynamics+of+CSF+and+plasma+A%CE%B2+reduction+after+treatment+with+JNJ-54861911%2C+a+potent+oral+BACE+inhibitor&doi=10.1016%2Fj.trci.2016.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span></div><div class="casAuthors">Timmers Maarten; Van Broeck Bianca; De Waepenaert Katja; Russu Alberto; Stieltjes Hans; Moechars Dieder; Mercken Marc; Kemp John; Van Nueten Luc; Tritsmans Luc; Streffer Johannes Rolf; Timmers Maarten; Engelborghs Sebastiaan; Streffer Johannes Rolf; Ramael Steven; Slemmon John; Liu Enchi; Bogert Jennifer; Shaw Leslie M; Engelborghs Sebastiaan; Sinha Vikash</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">202-212</span>
        ISSN:<span class="NLM_cas:issn">2352-8737</span>.
    </div><div class="casAbstract">OBJECTIVES:  Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor, JNJ-54861911, were assessed after single and multiple dosing in healthy participants.  METHODS:  Two randomized, placebo-controlled, double-blind studies were performed using single and multiple ascending JNJ-54861911 doses (up to 14 days) in young and elderly healthy participants.  Regular blood samples and frequent CSF samples, up to 36 hours after last dose, were collected to assess the pharmacokinetic and pharmacodynamic (Aβ, sAPPα,β,total levels) profiles of JNJ-54861911.  RESULTS:  JNJ-54861911 was well-tolerated, adverse events were uncommon and unrelated to JNJ-54861911.  JNJ-54861911 showed dose-proportional CSF and plasma pharmacokinetic profiles.  Plasma- and CSF-Aβ and CSF-sAPPβ were reduced in a dose-dependent manner.  Aβ reductions (up to 95%) outlasted exposure to JNJ-54861911.  APOE ε4 carrier status and baseline Aβ levels did not influence Aβ/sAPPβ reductions.  CONCLUSION:  JNJ-54861911, a potent brain-penetrant BACE1 inhibitor, achieved high and stable Aβ reductions after single and multiple dosing in healthy participants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRC88SOrTJcQDdblLE_E9PWfW6udTcc2eZm3TKSpvAZabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7kt1Wrtw%253D%253D&md5=46e0c106c2560f0b2c9aeba095fc20de</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2016.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2016.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DTimmers%26aufirst%3DM.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DRamael%26aufirst%3DS.%26aulast%3DSlemmon%26aufirst%3DJ.%26aulast%3DDe%2BWaepenaert%26aufirst%3DK.%26aulast%3DRussu%26aufirst%3DA.%26aulast%3DBogert%26aufirst%3DJ.%26aulast%3DStieltjes%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DEngelborghs%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DSinha%26aufirst%3DV.%26aulast%3DKemp%26aufirst%3DJ.%26aulast%3DVan%2BNueten%26aufirst%3DL.%26aulast%3DTritsmans%26aufirst%3DL.%26aulast%3DStreffer%26aufirst%3DJ.%2BR.%26atitle%3DProfiling%2520the%2520dynamics%2520of%2520CSF%2520and%2520plasma%2520A%25CE%25B2%2520reduction%2520after%2520treatment%2520with%2520JNJ-54861911%252C%2520a%2520potent%2520oral%2520BACE%2520inhibitor%26jtitle%3DAlzheimers%2520Dement%2520%2528N%2520Y%2529%26date%3D2016%26volume%3D2%26spage%3D202%26epage%3D212%26doi%3D10.1016%2Fj.trci.2016.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">The
Janssen Pharmaceutical Campanies of Johnson & Johnson</span>. <a href="https://www.janssen.com/ja/node/45771" class="extLink">https://www.janssen.com/ja/node/45771</a> (accessed December 23, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The%0AJanssen+Pharmaceutical+Campanies+of+Johnson+%26+Johnson.+https%3A%2F%2Fwww.janssen.com%2Fja%2Fnode%2F45771+%28accessed+December+23%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sako, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and centrally active 6-substituted 5-fluoro-1,3-dihydro-oxazine β-secretase (BACE1) inhibitors via active conformation stabilization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5525</span>– <span class="NLM_lpage">5546</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVarsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5525-5546&author=K.+Nakaharaauthor=K.+Fuchinoauthor=K.+Komanoauthor=N.+Asadaauthor=G.+Tadanoauthor=T.+Hasegawaauthor=T.+Yamamotoauthor=Y.+Sakoauthor=M.+Ogawaauthor=C.+Unemuraauthor=M.+Hosonoauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=S.+Ohnishiauthor=Y.+Kidoauthor=T.+Fukushimaauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=H.+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-I.+Kusakabe&title=Discovery+of+potent+and+centrally+active+6-substituted+5-fluoro-1%2C3-dihydro-oxazine+%CE%B2-secretase+%28BACE1%29+inhibitors+via+active+conformation+stabilization&doi=10.1021%2Facs.jmedchem.8b00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization</span></div><div class="casAuthors">Nakahara, Kenji; Fuchino, Kouki; Komano, Kazuo; Asada, Naoya; Tadano, Genta; Hasegawa, Tsuyoshi; Yamamoto, Takahiko; Sako, Yusuke; Ogawa, Masayoshi; Unemura, Chie; Hosono, Motoko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Ohnishi, Shuichi; Kido, Yasuto; Fukushima, Tamio; Dhuyvetter, Deborah; Borghys, Herman; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5525-5546</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">β-Secretase (BACE1) has an essential role in the prodn. of amyloid β peptides that accumulate in patients with Alzheimer's disease (AD).  Thus, inhibition of BACE1 is considered to be a disease-modifying approach for the treatment of AD.  The authors' hit-to-lead efforts led to a cellular potent 1,3-dihydro-oxazine I, which however inhibited hERG and showed high P-gp efflux.  The close analog of 5-fluoro-oxazine II reduced P-gp efflux; further introduction of electron withdrawing groups at the 6-position improved potency and also mitigated P-gp efflux and hERG inhibition.  Changing to a pyrazine followed by optimization of substituents on both the oxazine and the pyrazine culminated in III with robust Aβ redn. in vivo at low doses as well as reduced CYP2D6 inhibition.  On the basis of the X-ray anal. and the QM calcn. of given dihydro-oxazines, it was reasoned that the substituents at the 6-position as well as the 5-fluorine on the oxazine would stabilize a bioactive conformation to increase potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBTrC8rX3RE7Vg90H21EOLACvtfcHk0ljw4ofvG5xsdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVarsLs%253D&md5=e622beaca28e64ea0da30c87d0828086</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00011%26sid%3Dliteratum%253Aachs%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DSako%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DUnemura%26aufirst%3DC.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DOhnishi%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520centrally%2520active%25206-substituted%25205-fluoro-1%252C3-dihydro-oxazine%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520via%2520active%2520conformation%2520stabilization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5525%26epage%3D5546%26doi%3D10.1021%2Facs.jmedchem.8b00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurose, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyajima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiroyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyabu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J.M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Rational design of novel 1,3-oxazine based β-secretase (BACE1) inhibitors: Incorporation of a double bond to reduce P-gpefflux leading to robust Aβ reduction in the brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5122</span>– <span class="NLM_lpage">5137</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptVWhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5122-5137&author=K.+Fuchinoauthor=Y.+Mitsuokaauthor=M.+Masuiauthor=N.+Kuroseauthor=S.+Yoshidaauthor=K.+Komanoauthor=T.+Yamamotoauthor=M.+Ogawaauthor=C.+Unemuraauthor=M.+Hosonoauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=S.+Ohnishiauthor=Y.+Kidoauthor=T.+Fukushimaauthor=H.+Miyajimaauthor=S.+Hiroyamaauthor=K.+Koyabuauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=H.+J.M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-I.+Kusakabe&title=Rational+design+of+novel+1%2C3-oxazine+based+%CE%B2-secretase+%28BACE1%29+inhibitors%3A+Incorporation+of+a+double+bond+to+reduce+P-gpefflux+leading+to+robust+A%CE%B2+reduction+in+the+brain&doi=10.1021%2Facs.jmedchem.8b00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain</span></div><div class="casAuthors">Fuchino, Kouki; Mitsuoka, Yasunori; Masui, Moriyasu; Kurose, Noriyuki; Yoshida, Shuhei; Komano, Kazuo; Yamamoto, Takahiko; Ogawa, Masayoshi; Unemura, Chie; Hosono, Motoko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Ohnishi, Shuichi; Kido, Yasuto; Fukushima, Tamio; Miyajima, Hirofumi; Hiroyama, Shuichi; Koyabu, Kiyotaka; Dhuyvetter, Deborah; Borghys, Herman; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5122-5137</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Accumulation of Aβ peptides is a hallmark of Alzheimer's disease (AD) and is considered a causal factor in the pathogenesis of AD.  β-Secretase (BACE1) is a key enzyme responsible for producing Aβ peptides, and thus agents that inhibit BACE1 should be beneficial for disease-modifying treatment of AD.  Here we describe the discovery and optimization of novel oxazine-based BACE1 inhibitors by lowering amidine basicity with the incorporation of a double bond to improve brain penetration.  Starting from a 1,3-dihydrooxazine lead I identified by a hit-to-lead SAR following HTS, we adopted a pKa lowering strategy to reduce the P-gp efflux and the high hERG potential leading to the discovery of II that produced significant Aβ redn. with long duration in pharmacodynamic models and exhibited wide safety margins in cardiovascular safety models.  This compd. II improved the brain-to-plasma ratio relative to I by reducing P-gp recognition, which was demonstrated by a P-gp knockout mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGPZsGRa22ZLVg90H21EOLACvtfcHk0ljw4ofvG5xsdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptVWhsLo%253D&md5=ac366bddfe3492a0a47ce02918b5ea41</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00002%26sid%3Dliteratum%253Aachs%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DMitsuoka%26aufirst%3DY.%26aulast%3DMasui%26aufirst%3DM.%26aulast%3DKurose%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DUnemura%26aufirst%3DC.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DOhnishi%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DMiyajima%26aufirst%3DH.%26aulast%3DHiroyama%26aufirst%3DS.%26aulast%3DKoyabu%26aufirst%3DK.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.M.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DRational%2520design%2520of%2520novel%25201%252C3-oxazine%2520based%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%253A%2520Incorporation%2520of%2520a%2520double%2520bond%2520to%2520reduce%2520P-gpefflux%2520leading%2520to%2520robust%2520A%25CE%25B2%2520reduction%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5122%26epage%3D5137%26doi%3D10.1021%2Facs.jmedchem.8b00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, M. D.</span></span> <span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1410</span>, <span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+A+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0lgyokfYiLkc1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520A%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidolf, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolgos, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span> <span> </span><span class="NLM_article-title">In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1616</span>– <span class="NLM_lpage">1632</span>, <span class="refDoi"> DOI: 10.1021/tx300091x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx300091x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=1616-1632&author=R.+A.+Thompsonauthor=E.+M.+Isinauthor=Y.+Liauthor=L.+Weidolfauthor=K.+Pageauthor=I.+Wilsonauthor=S.+Swallowauthor=B.+Middletonauthor=S.+Stahlauthor=A.+J.+Fosterauthor=H.+Dolgosauthor=R.+Weaverauthor=J.+G.+Kenna&title=In+vitro+approach+to+assess+the+potential+for+risk+of+idiosyncratic+adverse+reactions+caused+by+candidate+drugs&doi=10.1021%2Ftx300091x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs</span></div><div class="casAuthors">Thompson, Richard A.; Isin, Emre M.; Li, Yan; Weidolf, Lars; Page, Ken; Wilson, Ian; Swallow, Steve; Middleton, Brian; Stahl, Simone; Foster, Alison J.; Dolgos, Hugues; Weaver, Richard; Kenna, J. Gerry</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1616-1632</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Idiosyncratic adverse drug reactions (IADRs) in humans can result in a broad range of clin. significant toxicities leading to attrition during drug development as well as postlicensing withdrawal or labeling.  IADRs arise from both drug and patient related mechanisms and risk factors.  Drug related risk factors, resulting from parent compd. or metabolites, may involve multiple contributory mechanisms including organelle toxicity, effects related to compd. disposition, and/or immune activation.  In the current study, we evaluate an in vitro approach, which explored both cellular effects and covalent binding (CVB) to assess IADR risks for drug candidates using 36 drugs which caused different patterns and severities of IADRs in humans.  The cellular effects were tested in an in vitro Panel of five assays which quantified (1) toxicity to THLE cells (SV40 T-antigen-immortalized human liver epithelial cells), which do not express P450s, (2) toxicity to a THLE cell line which selectively expresses P 450 3A4, (3) cytotoxicity in HepG2 cells in glucose and galactose media, which is indicative of mitochondrial injury, (4) inhibition of the human bile salt export pump, BSEP, and (5) inhibition of the rat multidrug resistance assocd. protein 2, Mrp2.  In addn., the CVB Burden was estd. by detg. the CVB of radiolabeled compd. to human hepatocytes and factoring in both the max. prescribed daily dose and the fraction of metab. leading to CVB.  Combining the aggregated results from the in vitro Panel assays with the CVB Burden data discriminated, with high specificity (78%) and sensitivity (100%), between 27 drugs, which had severe or marked IADR concern, and 9 drugs, which had low IADR concern, we propose that this integrated approach has the potential to enable selection of drug candidates with reduced propensity to cause IADRs in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFG8lfWXT4vLVg90H21EOLACvtfcHk0lgyokfYiLkc1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqs70%253D&md5=e657aaf23d4efc5466bca68dee95bded</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Ftx300091x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx300091x%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DR.%2BA.%26aulast%3DIsin%26aufirst%3DE.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWeidolf%26aufirst%3DL.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DA.%2BJ.%26aulast%3DDolgos%26aufirst%3DH.%26aulast%3DWeaver%26aufirst%3DR.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26atitle%3DIn%2520vitro%2520approach%2520to%2520assess%2520the%2520potential%2520for%2520risk%2520of%2520idiosyncratic%2520adverse%2520reactions%2520caused%2520by%2520candidate%2520drugs%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2012%26volume%3D25%26spage%3D1616%26epage%3D1632%26doi%3D10.1021%2Ftx300091x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">Representative thiazine-based BACE1 inhibitors:</p></div><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, N.</span>; <span class="NLM_string-name">Ueda, K.</span>; <span class="NLM_string-name">Itoh, N.</span>; <span class="NLM_string-name">Suzuki, S.</span>; <span class="NLM_string-name">Sakaguchi, G.</span>; <span class="NLM_string-name">Kato, A.</span>; <span class="NLM_string-name">Yukimasa, A.</span>; <span class="NLM_string-name">Hori, A.</span>; <span class="NLM_string-name">Kooriyama, Y.</span>; <span class="NLM_string-name">Haraguchi, H.</span>; <span class="NLM_string-name">Yasui, K.</span>; <span class="NLM_string-name">Kanda, Y.</span></span> <i>Preparation of 2-Amino-4-phenyl-4,5-dihydro-5H-1,3-thiazine Derivatives and Related Compounds for Treatment of Alzheimer’s Disease</i>. WO <span class="NLM_patent">2008133273 A1</span> November 6, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=N.+Kobayashi&author=K.+Ueda&author=N.+Itoh&author=S.+Suzuki&author=G.+Sakaguchi&author=A.+Kato&author=A.+Yukimasa&author=A.+Hori&author=Y.+Kooriyama&author=H.+Haraguchi&author=K.+Yasui&author=Y.+Kanda&title=Preparation+of+2-Amino-4-phenyl-4%2C5-dihydro-5H-1%2C3-thiazine+Derivatives+and+Related+Compounds+for+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DN.%26jtitle%3DPreparation%2520of%25202-Amino-4-phenyl-4%252C5-dihydro-5H-1%252C3-thiazine%2520Derivatives%2520and%2520Related%2520Compounds%2520for%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBell, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span> <span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with anorally available, non-peptidic β-secretase inhibitor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">16507</span>– <span class="NLM_lpage">16516</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+S.+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+anorally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lgUQYb__pXxlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DLaBell%26aufirst%3DE.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520anorally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span> <span> </span><span class="NLM_article-title">Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1inhibition in a dog model</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.3233/JAD-130599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.3233%2FJAD-130599" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=39-48&author=H.+Borghysauthor=T.+Jacobsauthor=B.+Van+Broeckauthor=L.+Dillenauthor=D.+Dhuyvetterauthor=H.+Gijsenauthor=M.+Mercken&title=Comparison+of+two+different+methods+for+measurement+of+amyloid-%CE%B2+peptides+in+cerebrospinal+fluid+after+BACE1inhibition+in+a+dog+model&doi=10.3233%2FJAD-130599"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3233%2FJAD-130599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130599%26sid%3Dliteratum%253Aachs%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DJacobs%26aufirst%3DT.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DDillen%26aufirst%3DL.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3DComparison%2520of%2520two%2520different%2520methods%2520for%2520measurement%2520of%2520amyloid-%25CE%25B2%2520peptides%2520in%2520cerebrospinal%2520fluid%2520after%2520BACE1inhibition%2520in%2520a%2520dog%2520model%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2013%26volume%3D38%26spage%3D39%26epage%3D48%26doi%3D10.3233%2FJAD-130599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dedrick, R.
L.</span></span> <i>J. Pharmacokinet. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>, <span class="refDoi"> DOI: 10.1007/BF01059667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1007%2FBF01059667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=4787619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADyaE2cXktVSjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dedrick%2C+R.%0AL.+J.+Pharmacokinet.+Biopharm.+1973%2C+1%2C+435%2C+10.1007%2FBF01059667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Animal scale-up</span></div><div class="casAuthors">Dedrick, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">435-61</span>CODEN:
                <span class="NLM_cas:coden">JPBPBJ</span>;
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    </div><div class="casAbstract">A discussion and review with 48 refs. on the relation of the pharmacokinetics of any given drug between one species and another.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxc7ybeYNg6LVg90H21EOLACvtfcHk0lgUQYb__pXxlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXktVSjsLg%253D&md5=e1e39e0a15f73685fc1139fb1b55cf45</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2FBF01059667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01059667%26sid%3Dliteratum%253Aachs%26aulast%3DDedrick%26aufirst%3DR.%2BL.%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharm.%26date%3D1973%26volume%3D1%26spage%3D435%26doi%3D10.1007%2FBF01059667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de
Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den Bossche, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span> <span> </span><span class="NLM_article-title">Optimization of 1,4-oxazineβ-secretase 1 (BACE1) inhibitors toward a clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5292</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00304</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVCgt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5292&author=H.+J.%0AM.+Gijsenauthor=S.+A.+Alonso+de%0ADiegoauthor=M.+De+Cleynauthor=A.+Garcia-Molinaauthor=G.+J.+Macdonaldauthor=C.+Martinez-Lamencaauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=F.+J.+R.+Romboutsauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=S.+Van+Brandtauthor=D.+Van+den+Bosscheauthor=M.+Van+Goolauthor=N.+Austinauthor=H.+Borghysauthor=D.+Dhuyvetterauthor=D.+Moechars&title=Optimization+of+1%2C4-oxazine%CE%B2-secretase+1+%28BACE1%29+inhibitors+toward+a+clinical+candidate&doi=10.1021%2Facs.jmedchem.8b00304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate</span></div><div class="casAuthors">Gijsen, Harrie J. M.; Alonso de Diego, Sergio A.; De Cleyn, Michel; Garcia-Molina, Aranzazu; Macdonald, Gregor J.; Martinez-Lamenca, Carolina; Oehlrich, Daniel; Prokopcova, Hana; Rombouts, Frederik J. R.; Surkyn, Michel; Trabanco, Andres A.; Van Brandt, Sven; Van den Bossche, Dries; Van Gool, Michiel; Austin, Nigel; Borghys, Herman; Dhuyvetter, Deborah; Moechars, Diederik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5292-5303</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In previous studies, the introduction of electron withdrawing groups to 1,4-oxazine BACE1 inhibitors reduced the pKa of the amidine group, resulting in compd. 2 that showed excellent in vivo efficacy, lowering Aβ levels in brain and CSF.  However, a suboptimal cardiovascular safety margin, based on QTc prolongation, prevented further progression.  Further optimization resulted in the replacement of the 2-fluoro substituent by a CF3-group, which reduced hERG inhibition.  This has led to compd. 3, with an improved cardiovascular safety margin and sufficiently safe in GLP toxicity studies to progress into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF682roZxPn7Vg90H21EOLACvtfcHk0lgCQ3U5Pr1ZzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVCgt7zP&md5=f6e061004a3c5ad98b817ddd198940c7</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00304%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DGarcia-Molina%26aufirst%3DA.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVan%2Bden%2BBossche%26aufirst%3DD.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DMoechars%26aufirst%3DD.%26atitle%3DOptimization%2520of%25201%252C4-oxazine%25CE%25B2-secretase%25201%2520%2528BACE1%2529%2520inhibitors%2520toward%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5292%26doi%3D10.1021%2Facs.jmedchem.8b00304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T.</span></span> <span> </span><span class="NLM_article-title">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">921</span>– <span class="NLM_lpage">931</span>, <span class="refDoi"> DOI: 10.1517/17425250903042318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1517%2F17425250903042318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=19519283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=921-931&author=D.+A.+Priceauthor=J.+Blaggauthor=L.+Jonesauthor=N.+Greeneauthor=T.+Wager&title=Physicochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes%3A+a+review&doi=10.1517%2F17425250903042318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span></div><div class="casAuthors">Price, David A.; Blagg, Julian; Jones, Lyn; Greene, Nigel; Wager, Travis</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">921-931</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The genesis of any toxicol. or safety outcome is multifactorial and complex; for this reason, it can be difficult for drug discovery projects to factor the avoidance of toxicity outcomes into their target design.  A focus on readily measurable parameters from high-throughput in vitro assays (e.g., primary potency, clearance) is easier to handle and have become the mainstays of drug discovery projects.  However, the fundamental origins of adverse safety or toxicity findings can be considered as deriving from four parameters, all of which are in the control of the drug designer.  These can be described as primary pharmacol., off target pharmacol., the presence of a defined structural fragment that can be assocd. with adverse outcomes and the overall physicochem. properties of the mol. that may predispose it to adverse outcomes.  In the drug discovery community, there has been recognition for many years of the influence of physicochem. drug properties (in particular lipophilicity) on the toxicol. profile of compds., and recent research is now beginning to quantify that risk in a probabilistic sense.  This review focuses on the overall properties of classes of mols. that are assocd. with an increased probability of adverse outcomes in in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU8kwwUsaFIrVg90H21EOLACvtfcHk0lgCQ3U5Pr1ZzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D&md5=bd1cca3634afda14de2f8aa115d7d55e</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1517%2F17425250903042318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903042318%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DWager%26aufirst%3DT.%26atitle%3DPhysicochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%253A%2520a%2520review%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2009%26volume%3D5%26spage%3D921%26epage%3D931%26doi%3D10.1517%2F17425250903042318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kazuki Fujimoto, Shuhei Yoshida, Genta Tadano, Naoya Asada, Kouki Fuchino, Shinji Suzuki, Eriko Matsuoka, Takahiko Yamamoto, Shiho Yamamoto, Shigeru Ando, Naoki Kanegawa, Yutaka Tonomura, Hisanori Ito, Diederik Moechars, Frederik J. R. Rombouts, Harrie J. M. Gijsen, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3075-3085. <a href="https://doi.org/10.1021/acs.jmedchem.0c01858" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01858%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BApproaches%252Bto%252BImproving%252BSelectivity%252Bthrough%252BUtilizing%252BExplicit%252BWater%252BMolecules%25253A%252BDiscovery%252Bof%252BSelective%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%252Bover%252BBACE2%26aulast%3DFujimoto%26aufirst%3DKazuki%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26102020%26date%3D15032021%26volume%3D64%26issue%3D6%26spage%3D3075%26epage%3D3085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuji Koriyama, Akihiro Hori, Hisanori Ito, Shuji Yonezawa, Yoshiyasu Baba, Norihiko Tanimoto, Tatsuhiko Ueno, Shiho Yamamoto, Takahiko Yamamoto, Naoya Asada, Kenji Morimoto, Shunsuke Einaru, Katsunori Sakai, Takushi Kanazu, Akihiro Matsuda, Yoshitaka Yamaguchi, Takuya Oguma, Maarten Timmers, Luc Tritsmans, Ken-ichi Kusakabe, Akira Kato, <span class="NLM_string-name hlFld-ContribAuthor">Gaku Sakaguchi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 1873-1888. <a href="https://doi.org/10.1021/acs.jmedchem.0c01917" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01917%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAtabecestat%252B%252528JNJ-54861911%252529%25253A%252BA%252BThiazine-Based%252B%2525CE%2525B2-Amyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252BInhibitor%252BAdvanced%252Bto%252Bthe%252BPhase%252B2b%25252F3%252BEARLY%252BClinical%252BTrial%26aulast%3DKoriyama%26aufirst%3DYuji%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D05112020%26date%3D15022021%26volume%3D64%26issue%3D4%26spage%3D1873%26epage%3D1888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mihirbaran Mandal, Alexei Buevich, John P. Caldwell, Lynn Hyde, Xianhai Huang, Xiaoxiang Liu, Brian McKittrick, Robert D. Mazzola, Dmitri Pissarnitski, Anandan Palani, Lili Zhang, Eric Parker, Li Xiao, Diane Rindgen, <span class="NLM_string-name hlFld-ContribAuthor">Zhaoning Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of Leads for γ-Secretase Modulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8216-8230. <a href="https://doi.org/10.1021/acs.jmedchem.0c00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeneration%252Bof%252BLeads%252Bfor%252B%2525CE%2525B3-Secretase%252BModulation%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16032020%26date%3D04082020%26date%3D27072020%26volume%3D63%26issue%3D15%26spage%3D8216%26epage%3D8230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>, <span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 25-52. <a href="https://doi.org/10.1080/13543776.2021.1832463" title="DOI URL">https://doi.org/10.1080/13543776.2021.1832463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1832463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1832463%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BBACE1%252Binhibitors%25253A%252Ba%252Bpatent%252Bliterature%252Breview%252B%2525282011%252Bto%252B2020%252529%26aulast%3DRombouts%26aufirst%3DFrederik%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D1%26spage%3D25%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renata P.  Sakata</span>, <span class="hlFld-ContribAuthor ">Giorgio  Antoniolli</span>, <span class="hlFld-ContribAuthor ">Marcelo  Lancellotti</span>, <span class="hlFld-ContribAuthor ">Daniel Fabio  Kawano</span>, <span class="hlFld-ContribAuthor ">Euzébio  Guimarães Barbosa</span>, <span class="hlFld-ContribAuthor ">Wanda P.  Almeida</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 2′-Aminochalcone: A multi-target approach to find drug candidates to treat Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>103 </em>, 104201. <a href="https://doi.org/10.1016/j.bioorg.2020.104201" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104201%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2%2525E2%252580%2525B2-Aminochalcone%25253A%252BA%252Bmulti-target%252Bapproach%252Bto%252Bfind%252Bdrug%252Bcandidates%252Bto%252Btreat%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSakata%26aufirst%3DRenata%2BP.%26date%3D2020%26volume%3D103%26spage%3D104201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01140&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. BACE1 Inhibitors <b>1</b> and <b>5</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01140&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of compound <b>5</b> from the lead <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01140&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01140&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) DIBAL, DCM, −78 °C, (ii) MePPh<sub>3</sub>Br, KO<i>t</i>-Bu, toluene, rt, 39%; (b) (i) HCl in dioxane, DCM, rt, (ii) BzNCS, DCM, rt, 95%; (c) I<sub>2</sub>, MeCN, 0 °C, 82%; (d) <i>n</i>-Bu<sub>3</sub>SnH, AIBN, toluene, 80 °C, 90%; (e) hydrazine monohydrate, EtOH, rt, 91%; (f) (i) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>-TFA, −20 °C, (ii) Fe, NH<sub>4</sub>Cl, toluene-H<sub>2</sub>O, 80 °C, (iii) 5-(fluoromethoxy)pyrazine-2-carboxylic acid, HCl, EDC·HCl, MeOH, 0 °C to rt, 91%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time course effects of <b>5</b> on total brain Aβ reduction (vs vehicle control), plasma, and brain concentrations in male Crl:CD1 (ICR) mice (6 to 8 weeks old, <i>n</i> = 4) after 1 and 3 mg/kg oral doses as a solution of 20% hydroxypropyl-β-cyclodextrin (HPBCD).<a onclick="showRef(event, 'cit11a cit11b'); return false;" href="javascript:void(0);" class="ref cit11a cit11b">(11a,b)</a> Total Ab reductions (% reduction; red) and brain concentrations (ng/g; black) are shown by solid lines, and plasma concentrations (ng/mL; black) are shown by dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01140&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/medium/jm9b01140_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. CSF Aβ<sub>42</sub> reduction in beagle dogs after oral dose of compound <b>5</b> as a solution in 20% HPBCD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01140/20191018/images/large/jm9b01140_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01140&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03518" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03518" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 16 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, M.</span>; <span class="NLM_string-name">Comas-Herrera, A.</span>; <span class="NLM_string-name">Knapp, M.</span>; <span class="NLM_string-name">Guerchet, M.</span>; <span class="NLM_string-name">Karagiannidou, M.</span></span> <span> </span><span class="NLM_article-title">World Alzheimer Report 2016</span>. <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf" class="extLink">https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf</a> (accessed February 20, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Prince&author=A.+Comas-Herrera&author=M.+Knapp&author=M.+Guerchet&author=M.+Karagiannidou&title=World+Alzheimer+Report+2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26atitle%3DWorld%2520Alzheimer%2520Report%25202016%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease at 25 years</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.15252/emmm.201606210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.15252%2Femmm.201606210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=27025652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=595-608&author=D.+J.+Selkoeauthor=J.+Hardy&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease+at+25+years&doi=10.15252%2Femmm.201606210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease at 25 years</span></div><div class="casAuthors">Selkoe, Dennis J.; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">595-608</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Despite continuing debate about the amyloid β-protein or Aβ hypothesis, new lines of evidence from labs. and clinics worldwide support the concept that an imbalance between prodn. and clearance of Aβ42 and related Aβ peptides is a very early, often initiating factor in Alzheimer's disease AD.  Confirmation that presenilin is the catalytic site of γ-secretase has provided a linchpin: all dominant mutations causing early-onset AD occur either in the substrate amyloid precursor protein, APP or the protease presenilin of the reaction that generates Aβ.  Duplication of the wild-type APP gene in Down's syndrome leads to Aβ deposits in the teens, followed by microgliosis, astrocytosis, and neurofibrillary tangles typical of AD.  Apolipoprotein E4, which predisposes to AD in > 40% of cases, has been found to impair Aβ clearance from the brain.  Sol. oligomers of Aβ42 isolated from AD patients' brains can decrease synapse no., inhibit long-term potentiation, and enhance long-term synaptic depression in rodent hippocampus, and injecting them into healthy rats impairs memory.  The human oligomers also induce hyperphosphorylation of tau at AD-relevant epitopes and cause neuritic dystrophy in cultured neurons.  Crossing human APP with human tau transgenic mice enhances tau-pos. neurotoxicity.  In humans, new studies show that low cerebrospinal fluid CSF Aβ42 and amyloid-PET positivity precede other AD manifestations by many years.  Most importantly, recent trials of three different Aβ antibodies solanezumab, crenezumab, and aducanumab have suggested a slowing of cognitive decline in post hoc analyses of mild AD subjects.  Although many factors contribute to AD pathogenesis, Aβ dyshomeostasis has emerged as the most extensively validated and compelling therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGo1qmyvVtbVg90H21EOLACvtfcHk0lgdoJ-lcDseIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D&md5=b7a2003ba5d341f5eef5c7e9454235ce</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.15252%2Femmm.201606210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201606210%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520at%252025%2520years%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D595%26epage%3D608%26doi%3D10.15252%2Femmm.201606210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaedal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulem, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudbjartsson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhangale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenlocher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsdottir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreassen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jönsson, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palotie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsteinsdottir, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, K.</span></span> <span> </span><span class="NLM_article-title">A mutation in APPprotects against Alzheimer’s disease and age-related cognitive decline</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APPprotects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lhFMUkwP1aZCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APPprotects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the β secretase BACE1 for Alzheimer’s disease therapy</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(13)70276-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1016%2FS1474-4422%2813%2970276-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=24556009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=319-329&author=R.+Yanauthor=R.+Vassar&title=Targeting+the+%CE%B2+secretase+BACE1+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1016%2FS1474-4422%2813%2970276-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the β secretase BACE1 for Alzheimer's disease therapy</span></div><div class="casAuthors">Yan, Riqiang; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-329</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The β secretase, widely known as β-site amyloid precursor protein cleaving enzyme 1 (BACE1), initiates the prodn. of the toxic amyloid β (Aβ) that plays a crucial early part in Alzheimer's disease pathogenesis.  BACE1 is a prime therapeutic target for lowering cerebral Aβ concns. in Alzheimer's disease, and clin. development of BACE1 inhibitors is being intensely pursued.  Although BACE1 inhibitor drug development has proven challenging, several promising BACE1 inhibitors have recently entered human clin. trials.  The safety and efficacy of these drugs are being tested at present in healthy individuals and patients with Alzheimer's disease, and will soon be tested in individuals with presymptomatic Alzheimer's disease.  Although hopes are high that BACE1 inhibitors might be efficacious for the prevention or treatment of Alzheimer's disease, concerns have been raised about potential mechanism-based side-effects of these drugs.  The potential of therapeutic BACE1 inhibition might prove to be a watershed in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8SsSfCAC6nbVg90H21EOLACvtfcHk0lhFMUkwP1aZCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D&md5=11aeb06fee19cafc0b361e2c43900806</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970276-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970276-X%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520%25CE%25B2%2520secretase%2520BACE1%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D319%26epage%3D329%26doi%3D10.1016%2FS1474-4422%2813%2970276-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Theevolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=Theevolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0lh_A-Ahwg47ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DTheevolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A.</span>; <span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Targeting β-secretase (BACE) for the treatment of Alzheimer’s disease</span>. In  <i>Comprehensive Medicinal Chemistry III</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>, <span class="NLM_string-name">Rotella, D. P.</span>, <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2017</span>; Vol.  <span class="NLM_volume">7</span>, pp  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">383</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1016%2FB978-0-12-409547-2.13809-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=326-383&author=A.+Hall&author=H.+J.+M.+Gijsenauthor=S.+Chackalamannil&author=D.+P.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DA.%26atitle%3DTargeting%2520%25CE%25B2-secretase%2520%2528BACE%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26volume%3D7%26spage%3D326%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">761</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.12.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1016%2Fj.bmcl.2018.12.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=30709653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=761&author=C.-C.+Hsiaoauthor=F.+Romboutsauthor=H.+J.+M.+Gijsen&title=New+evolutions+in+the+BACE1+inhibitor+field+from+2014+to+2018&doi=10.1016%2Fj.bmcl.2018.12.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span></div><div class="casAuthors">Hsiao, Chien-Chi; Rombouts, Frederik; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">761-777</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors offer the potential of disease-modifying treatment for Alzheimer's disease (AD).  Since 2014, major breakthroughs have appeared in the field of BACE1 inhibitors.  This review provides an overview of amidine-based BACE1 inhibitors between 2014 and 2018.  Herein are summarized (i) the structure-activity relationship, (ii) the physiol. results and (iii) the potential risks from a lack of selectivity.  This review also summarizes clin. scope, results and outlook of the compds. that have been or are currently under development in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3OfI_B-BJ-LVg90H21EOLACvtfcHk0lh_A-Ahwg47ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D&md5=049eda6ce97b31a04b5b579afd3e11e5</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DC.-C.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DNew%2520evolutions%2520in%2520the%2520BACE1%2520inhibitor%2520field%2520from%25202014%2520to%25202018%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D761%26doi%3D10.1016%2Fj.bmcl.2018.12.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)-A β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29-A+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0lh_A-Ahwg47ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529-A%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furtek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahoney, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozley, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberghe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelson, D.</span></span> <span> </span><span class="NLM_article-title">Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">1691</span>– <span class="NLM_lpage">1703</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1706441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1056%2FNEJMoa1706441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=29719179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsFyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2018&pages=1691-1703&author=M.+F.+Eganauthor=J.+Kostauthor=P.+N.+Tariotauthor=P.+S.+Aisenauthor=J.+L.+Cummingsauthor=B.+Vellasauthor=C.+Surauthor=Y.+Mukaiauthor=T.+Vossauthor=C.+Furtekauthor=E.+Mahoneyauthor=L.+H.+Mozleyauthor=R.+Vandenbergheauthor=Y.+Moauthor=D.+Michelson&title=Randomized+trial+of+verubecestat+for+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1706441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Egan, Michael F.; Kost, James; Tariot, Pierre N.; Aisen, Paul S.; Cummings, Jeffrey L.; Vellas, Bruno; Sur, Cyrille; Mukai, Yuki; Voss, Tiffini; Furtek, Christine; Mahoney, Erin; Mozley, Lyn Harper; Vandenberghe, Rik; Mo, Yi; Michelson, David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1691-1703</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease is characterized by the deposition of amyloid-beta (Aβ) plaques in the brain.  Aβ is produced from the sequential cleavage of amyloid precursor protein by β-site amyloid precursor protein-cleaving enzyme 1 (BACE-1) followed by γ-secretase.  Verubecestat is an oral BACE-1 inhibitor that reduces the Aβ level in the cerebrospinal fluid of patients with Alzheimer's disease.  Methods: We conducted a randomized, double-blind, placebo-controlled, 78-wk trial to evaluate verubecestat at doses of 12 mg and 40 mg per day, as compared with placebo, in patients who had a clin. diagnosis of mild-to-moderate Alzheimer's disease.  The coprimary outcomes were the change from baseline to week 78 in the score on the cognitive subscale of the Alzheimer's disease Assessment Scale (ADAS-cog; scores range from 0 to 70, with higher scores indicating worse dementia) and in the score on the Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory scale (ADCS-ADL; scores range from 0 to 78, with lower scores indicating worse function).  Results: A total of 1958 patients underwent randomization; 653 were randomly assigned to receive verubecestat at a dose of 12 mg per day (the 12-mg group), 652 to receive verubecestat at a dose of 40 mg per day (the 40-mg group), and 653 to receive matching placebo.  The trial was terminated early for futility 50 mo after onset, which was within 5 mo before its scheduled completion, and after enrollment of the planned 1958 patients was complete.  The estd. mean change from baseline to week 78 in the ADAS-cog score was 7.9 in the 12-mg group, 8.0 in the 40-mg group, and 7.7 in the placebo group (P = 0.63 for the comparison between the 12-mg group and the placebo group and P = 0.46 for the comparison between the 40-mg group and the placebo group).  The estd. mean change from baseline to week 78 in the ADCS-ADL score was -8.4 in the 12-mg group, -8.2 in the 40-mg group, and -8.9 in the placebo group (P = 0.49 for the comparison between the 12-mg group and the placebo group and P = 0.32 for the comparison between the 40-mg group and the placebo group).  Adverse events, including rash, falls and injuries, sleep disturbance, suicidal ideation, wt. loss, and hair-color change, were more common in the verubecestat groups than in the placebo group. conclusions Verubecestat did not reduce cognitive or functional decline in patients with mild-to-moderate Alzheimer's disease and was assocd. with treatment-related adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroW5Tf-VIj2LVg90H21EOLACvtfcHk0ligPhbw4QAVXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsFyqsbs%253D&md5=e6ecfbd2981616b343468ae8bed1db2d</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1706441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1706441%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DM.%2BF.%26aulast%3DKost%26aufirst%3DJ.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DMukai%26aufirst%3DY.%26aulast%3DVoss%26aufirst%3DT.%26aulast%3DFurtek%26aufirst%3DC.%26aulast%3DMahoney%26aufirst%3DE.%26aulast%3DMozley%26aufirst%3DL.%2BH.%26aulast%3DVandenberghe%26aufirst%3DR.%26aulast%3DMo%26aufirst%3DY.%26aulast%3DMichelson%26aufirst%3DD.%26atitle%3DRandomized%2520trial%2520of%2520verubecestat%2520for%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2018%26volume%3D378%26spage%3D1691%26epage%3D1703%26doi%3D10.1056%2FNEJMoa1706441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Merck &
Co., Inc</span>. <a href="https://investors.merck.com/news/press-release-details/2018/Merck-Announces-Discontinuation-of-APECS-Study-Evaluating-Verubecestat-MK-8931-for-the-Treatment-of-People-with-Prodromal-Alzheimers-Disease/default.aspx" class="extLink">https://investors.merck.com/news/press-release-details/2018/Merck-Announces-Discontinuation-of-APECS-Study-Evaluating-Verubecestat-MK-8931-for-the-Treatment-of-People-with-Prodromal-Alzheimers-Disease/default.aspx</a> (accessed January 7, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Merck+%26%0ACo.%2C+Inc.+https%3A%2F%2Finvestors.merck.com%2Fnews%2Fpress-release-details%2F2018%2FMerck-Announces-Discontinuation-of-APECS-Study-Evaluating-Verubecestat-MK-8931-for-the-Treatment-of-People-with-Prodromal-Alzheimers-Disease%2Fdefault.aspx+%28accessed+January+7%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjaell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspersson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogstedt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haeberlein, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, P.</span></span> <span> </span><span class="NLM_article-title">AZD3293: A novel, orally active BACE1 inhibitor with high potency and permeability and markedly slow off-rate kinetics</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1109</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.3233/JAD-150834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.3233%2FJAD-150834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=26890753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVKitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2016&pages=1109-1123&author=S.+Eketjaellauthor=J.+Jansonauthor=K.+Kasperssonauthor=A.+Bogstedtauthor=F.+Jeppssonauthor=J.+Faeltingauthor=S.+B.+Haeberleinauthor=A.+R.+Kuglerauthor=R.+C.+Alexanderauthor=G.+Cebersauthor=P.+Ho&title=AZD3293%3A+A+novel%2C+orally+active+BACE1+inhibitor+with+high+potency+and+permeability+and+markedly+slow+off-rate+kinetics&doi=10.3233%2FJAD-150834"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics</span></div><div class="casAuthors">Eketjaell, Susanna; Janson, Juliette; Kaspersson, Karin; Bogstedt, Anna; Jeppsson, Fredrik; Faelting, Johanna; Haeberlein, Samantha Budd; Kugler, Alan R.; Alexander, Robert C.; Cebers, Gvido; Ho, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1109-1123</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A growing body of pathol., biomarker, genetic, and mechanistic data suggests that amyloid accumulation, as a result of changes in prodn., processing, and/or clearance of brain amyloid-β peptide (Aβ) concns., plays a key role in the pathogenesis of Alzheimer's disease (AD).  Beta-secretase 1 (BACE1) mediates the first step in the processing of amyloid-β protein precursor (AβPP) to Aβ peptides, with the sol. N terminal fragment of AβPP (sAβPPβ) as a direct product, and BACE1 inhibition is an attractive target for therapeutic intervention to reduce the prodn. of Aβ.  Here, we report the in vitro and in vivo pharmacol. profile of AZD3293, a potent, highly permeable, orally active, blood-brain barrier (BBB) penetrating, BACE1 inhibitor with unique slow off-rate kinetics.  The in vitro potency of AZD3293 was demonstrated in several cellular models, including primary cortical neurons.  In vivo in mice, guinea pigs, and dogs, AZD3293 displayed significant dose- and time-dependent redns. in plasma, cerebrospinal fluid, and brain concns. of Aβ40, Aβ42, and sAβPPβ.  The in vitro potency of AZD3293 in mouse and guinea pig primary cortical neuronal cells was correlated to the in vivo potency expressed as free AZD3293 concns. in mouse and guinea pig brains.  In mice and dogs, the slow off-rate from BACE1 may have translated into a prolongation of the obsd. effect beyond the turnover rate of Aβ.  The preclin. data strongly support the clin. development of AZD3293, and patients with AD are currently being recruited into a combined Phase 2/3 study to test the disease-modifying properties of AZD3293.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJMi27mSRG67Vg90H21EOLACvtfcHk0ligPhbw4QAVXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVKitr8%253D&md5=6d022dd410874469f2fce43d463bd63c</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.3233%2FJAD-150834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-150834%26sid%3Dliteratum%253Aachs%26aulast%3DEketjaell%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKaspersson%26aufirst%3DK.%26aulast%3DBogstedt%26aufirst%3DA.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DFaelting%26aufirst%3DJ.%26aulast%3DHaeberlein%26aufirst%3DS.%2BB.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DHo%26aufirst%3DP.%26atitle%3DAZD3293%253A%2520A%2520novel%252C%2520orally%2520active%2520BACE1%2520inhibitor%2520with%2520high%2520potency%2520and%2520permeability%2520and%2520markedly%2520slow%2520off-rate%2520kinetics%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2016%26volume%3D50%26spage%3D1109%26epage%3D1123%26doi%3D10.3233%2FJAD-150834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alzforum</span>. <a href="https://www.alzforum.org/therapeutics/azd3293" class="extLink">https://www.alzforum.org/therapeutics/azd3293</a> (accessed December 23, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzforum.+https%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Fazd3293+%28accessed+December+23%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alzforum</span>. <a href="http://www.alzforum.org/therapeutics/elenbecestat" class="extLink">http://www.alzforum.org/therapeutics/elenbecestat</a> (accessed July 24, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzforum.+http%3A%2F%2Fwww.alzforum.org%2Ftherapeutics%2Felenbecestat+%28accessed+July+24%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span>; <span class="NLM_string-name">Motoki, T.</span>; <span class="NLM_string-name">Kaneko, T.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Ishida, T.</span>; <span class="NLM_string-name">Takeda, K.</span>; <span class="NLM_string-name">Kita, Y.</span>; <span class="NLM_string-name">Yamamoto, N.</span>; <span class="NLM_string-name">Khan, A.</span>; <span class="NLM_string-name">Dimopoulos, P.</span></span> <i>Preparation of condensed aminodihydrothiazine derivatives as inhibitors of β-site APP-cleaving enzyme 1 (BACE1)</i>. WO <span class="NLM_patent">2009091016 A1</span>, July 23, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Suzuki&author=T.+Motoki&author=T.+Kaneko&author=M.+Takaishi&author=T.+Ishida&author=K.+Takeda&author=Y.+Kita&author=N.+Yamamoto&author=A.+Khan&author=P.+Dimopoulos&title=Preparation+of+condensed+aminodihydrothiazine+derivatives+as+inhibitors+of+%CE%B2-site+APP-cleaving+enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DY.%26jtitle%3DPreparation%2520of%2520condensed%2520aminodihydrothiazine%2520derivatives%2520as%2520inhibitors%2520of%2520%25CE%25B2-site%2520APP-cleaving%2520enzyme%25201%2520%2528BACE1%2529%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ufer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouzade-Dominguez, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huledal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubost, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avrameas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezous, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vormfelde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez Lopez, C.</span></span> <span> </span><span class="NLM_article-title">The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer’s disease</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e9316</span> <span class="refDoi"> DOI: 10.15252/emmm.201809316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.15252%2Femmm.201809316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=30224383" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=U.+Neumannauthor=M.+Uferauthor=L.+H.+Jacobsonauthor=M.-L.+Rouzade-Dominguezauthor=G.+Huledalauthor=C.+Kollyauthor=R.+M.+Lueoendauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=K.+Hurthauthor=H.+Rueegerauthor=M.+Tintelnot-Blomleyauthor=M.+Staufenbielauthor=D.+R.+Shimshekauthor=L.+Perrotauthor=W.+Frieauffauthor=V.+Dubostauthor=H.+Schillerauthor=B.+Voggauthor=K.+Beltzauthor=A.+Avrameasauthor=S.+Kretzauthor=N.+Pezousauthor=J.+Rondeauauthor=N.+Beckmannauthor=A.+Hartmannauthor=S.+Vormfeldeauthor=O.+J.+Davidauthor=B.+Galliauthor=R.+Ramosauthor=A.+Grafauthor=C.+Lopez+Lopez&title=The+BACE-1+inhibitor+CNP520+for+prevention+trials+in+Alzheimer%E2%80%99s+disease&doi=10.15252%2Femmm.201809316"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.15252%2Femmm.201809316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201809316%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DUfer%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DRouzade-Dominguez%26aufirst%3DM.-L.%26aulast%3DHuledal%26aufirst%3DG.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DLueoend%26aufirst%3DR.%2BM.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DHurth%26aufirst%3DK.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DDubost%26aufirst%3DV.%26aulast%3DSchiller%26aufirst%3DH.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DAvrameas%26aufirst%3DA.%26aulast%3DKretz%26aufirst%3DS.%26aulast%3DPezous%26aufirst%3DN.%26aulast%3DRondeau%26aufirst%3DJ.%26aulast%3DBeckmann%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DVormfelde%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DO.%2BJ.%26aulast%3DGalli%26aufirst%3DB.%26aulast%3DRamos%26aufirst%3DR.%26aulast%3DGraf%26aufirst%3DA.%26aulast%3DLopez%2BLopez%26aufirst%3DC.%26atitle%3DThe%2520BACE-1%2520inhibitor%2520CNP520%2520for%2520prevention%2520trials%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2018%26volume%3D10%26doi%3D10.15252%2Femmm.201809316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Novartis AG</span>. <a href="https://www.globenewswire.com/news-release/2019/07/11/1881745/0/en/Novartis-Amgen-and-Banner-Alzheimer-s-Institute-discontinue-clinical-program-with-BACE-inhibitor-CNP520-for-Alzheimer-s-prevention.html" class="extLink">https://www.globenewswire.com/news-release/2019/07/11/1881745/0/en/Novartis-Amgen-and-Banner-Alzheimer-s-Institute-discontinue-clinical-program-with-BACE-inhibitor-CNP520-for-Alzheimer-s-prevention.html</a> (accessed September 1, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Novartis+AG.+https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2019%2F07%2F11%2F1881745%2F0%2Fen%2FNovartis-Amgen-and-Banner-Alzheimer-s-Institute-discontinue-clinical-program-with-BACE-inhibitor-CNP520-for-Alzheimer-s-prevention.html+%28accessed+September+1%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slemmon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Waepenaert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stieltjes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelborghs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nueten, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritsmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streffer, J. R.</span></span> <span> </span><span class="NLM_article-title">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span>. <i>Alzheimers Dement (N Y)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2016.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1016%2Fj.trci.2016.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=29067308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A280%3ADC%252BC1M7kt1Wrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=202-212&author=M.+Timmersauthor=B.+Van+Broeckauthor=S.+Ramaelauthor=J.+Slemmonauthor=K.+De+Waepenaertauthor=A.+Russuauthor=J.+Bogertauthor=H.+Stieltjesauthor=L.+M.+Shawauthor=S.+Engelborghsauthor=D.+Moecharsauthor=M.+Merckenauthor=E.+Liuauthor=V.+Sinhaauthor=J.+Kempauthor=L.+Van+Nuetenauthor=L.+Tritsmansauthor=J.+R.+Streffer&title=Profiling+the+dynamics+of+CSF+and+plasma+A%CE%B2+reduction+after+treatment+with+JNJ-54861911%2C+a+potent+oral+BACE+inhibitor&doi=10.1016%2Fj.trci.2016.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor</span></div><div class="casAuthors">Timmers Maarten; Van Broeck Bianca; De Waepenaert Katja; Russu Alberto; Stieltjes Hans; Moechars Dieder; Mercken Marc; Kemp John; Van Nueten Luc; Tritsmans Luc; Streffer Johannes Rolf; Timmers Maarten; Engelborghs Sebastiaan; Streffer Johannes Rolf; Ramael Steven; Slemmon John; Liu Enchi; Bogert Jennifer; Shaw Leslie M; Engelborghs Sebastiaan; Sinha Vikash</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">202-212</span>
        ISSN:<span class="NLM_cas:issn">2352-8737</span>.
    </div><div class="casAbstract">OBJECTIVES:  Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor, JNJ-54861911, were assessed after single and multiple dosing in healthy participants.  METHODS:  Two randomized, placebo-controlled, double-blind studies were performed using single and multiple ascending JNJ-54861911 doses (up to 14 days) in young and elderly healthy participants.  Regular blood samples and frequent CSF samples, up to 36 hours after last dose, were collected to assess the pharmacokinetic and pharmacodynamic (Aβ, sAPPα,β,total levels) profiles of JNJ-54861911.  RESULTS:  JNJ-54861911 was well-tolerated, adverse events were uncommon and unrelated to JNJ-54861911.  JNJ-54861911 showed dose-proportional CSF and plasma pharmacokinetic profiles.  Plasma- and CSF-Aβ and CSF-sAPPβ were reduced in a dose-dependent manner.  Aβ reductions (up to 95%) outlasted exposure to JNJ-54861911.  APOE ε4 carrier status and baseline Aβ levels did not influence Aβ/sAPPβ reductions.  CONCLUSION:  JNJ-54861911, a potent brain-penetrant BACE1 inhibitor, achieved high and stable Aβ reductions after single and multiple dosing in healthy participants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRC88SOrTJcQDdblLE_E9PWfW6udTcc2eaNjSFtlJXK77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7kt1Wrtw%253D%253D&md5=46e0c106c2560f0b2c9aeba095fc20de</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2016.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2016.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DTimmers%26aufirst%3DM.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DRamael%26aufirst%3DS.%26aulast%3DSlemmon%26aufirst%3DJ.%26aulast%3DDe%2BWaepenaert%26aufirst%3DK.%26aulast%3DRussu%26aufirst%3DA.%26aulast%3DBogert%26aufirst%3DJ.%26aulast%3DStieltjes%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DEngelborghs%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DSinha%26aufirst%3DV.%26aulast%3DKemp%26aufirst%3DJ.%26aulast%3DVan%2BNueten%26aufirst%3DL.%26aulast%3DTritsmans%26aufirst%3DL.%26aulast%3DStreffer%26aufirst%3DJ.%2BR.%26atitle%3DProfiling%2520the%2520dynamics%2520of%2520CSF%2520and%2520plasma%2520A%25CE%25B2%2520reduction%2520after%2520treatment%2520with%2520JNJ-54861911%252C%2520a%2520potent%2520oral%2520BACE%2520inhibitor%26jtitle%3DAlzheimers%2520Dement%2520%2528N%2520Y%2529%26date%3D2016%26volume%3D2%26spage%3D202%26epage%3D212%26doi%3D10.1016%2Fj.trci.2016.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">The
Janssen Pharmaceutical Campanies of Johnson & Johnson</span>. <a href="https://www.janssen.com/ja/node/45771" class="extLink">https://www.janssen.com/ja/node/45771</a> (accessed December 23, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The%0AJanssen+Pharmaceutical+Campanies+of+Johnson+%26+Johnson.+https%3A%2F%2Fwww.janssen.com%2Fja%2Fnode%2F45771+%28accessed+December+23%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sako, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and centrally active 6-substituted 5-fluoro-1,3-dihydro-oxazine β-secretase (BACE1) inhibitors via active conformation stabilization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5525</span>– <span class="NLM_lpage">5546</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpvVarsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5525-5546&author=K.+Nakaharaauthor=K.+Fuchinoauthor=K.+Komanoauthor=N.+Asadaauthor=G.+Tadanoauthor=T.+Hasegawaauthor=T.+Yamamotoauthor=Y.+Sakoauthor=M.+Ogawaauthor=C.+Unemuraauthor=M.+Hosonoauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=S.+Ohnishiauthor=Y.+Kidoauthor=T.+Fukushimaauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=H.+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-I.+Kusakabe&title=Discovery+of+potent+and+centrally+active+6-substituted+5-fluoro-1%2C3-dihydro-oxazine+%CE%B2-secretase+%28BACE1%29+inhibitors+via+active+conformation+stabilization&doi=10.1021%2Facs.jmedchem.8b00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization</span></div><div class="casAuthors">Nakahara, Kenji; Fuchino, Kouki; Komano, Kazuo; Asada, Naoya; Tadano, Genta; Hasegawa, Tsuyoshi; Yamamoto, Takahiko; Sako, Yusuke; Ogawa, Masayoshi; Unemura, Chie; Hosono, Motoko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Ohnishi, Shuichi; Kido, Yasuto; Fukushima, Tamio; Dhuyvetter, Deborah; Borghys, Herman; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5525-5546</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">β-Secretase (BACE1) has an essential role in the prodn. of amyloid β peptides that accumulate in patients with Alzheimer's disease (AD).  Thus, inhibition of BACE1 is considered to be a disease-modifying approach for the treatment of AD.  The authors' hit-to-lead efforts led to a cellular potent 1,3-dihydro-oxazine I, which however inhibited hERG and showed high P-gp efflux.  The close analog of 5-fluoro-oxazine II reduced P-gp efflux; further introduction of electron withdrawing groups at the 6-position improved potency and also mitigated P-gp efflux and hERG inhibition.  Changing to a pyrazine followed by optimization of substituents on both the oxazine and the pyrazine culminated in III with robust Aβ redn. in vivo at low doses as well as reduced CYP2D6 inhibition.  On the basis of the X-ray anal. and the QM calcn. of given dihydro-oxazines, it was reasoned that the substituents at the 6-position as well as the 5-fluorine on the oxazine would stabilize a bioactive conformation to increase potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBTrC8rX3RE7Vg90H21EOLACvtfcHk0ljdj39InPGzBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpvVarsLs%253D&md5=e622beaca28e64ea0da30c87d0828086</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00011%26sid%3Dliteratum%253Aachs%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DSako%26aufirst%3DY.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DUnemura%26aufirst%3DC.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DOhnishi%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520centrally%2520active%25206-substituted%25205-fluoro-1%252C3-dihydro-oxazine%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%2520via%2520active%2520conformation%2520stabilization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5525%26epage%3D5546%26doi%3D10.1021%2Facs.jmedchem.8b00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurose, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unemura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyajima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiroyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyabu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J.M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Rational design of novel 1,3-oxazine based β-secretase (BACE1) inhibitors: Incorporation of a double bond to reduce P-gpefflux leading to robust Aβ reduction in the brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5122</span>– <span class="NLM_lpage">5137</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptVWhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5122-5137&author=K.+Fuchinoauthor=Y.+Mitsuokaauthor=M.+Masuiauthor=N.+Kuroseauthor=S.+Yoshidaauthor=K.+Komanoauthor=T.+Yamamotoauthor=M.+Ogawaauthor=C.+Unemuraauthor=M.+Hosonoauthor=H.+Itoauthor=G.+Sakaguchiauthor=S.+Andoauthor=S.+Ohnishiauthor=Y.+Kidoauthor=T.+Fukushimaauthor=H.+Miyajimaauthor=S.+Hiroyamaauthor=K.+Koyabuauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=H.+J.M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-I.+Kusakabe&title=Rational+design+of+novel+1%2C3-oxazine+based+%CE%B2-secretase+%28BACE1%29+inhibitors%3A+Incorporation+of+a+double+bond+to+reduce+P-gpefflux+leading+to+robust+A%CE%B2+reduction+in+the+brain&doi=10.1021%2Facs.jmedchem.8b00002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain</span></div><div class="casAuthors">Fuchino, Kouki; Mitsuoka, Yasunori; Masui, Moriyasu; Kurose, Noriyuki; Yoshida, Shuhei; Komano, Kazuo; Yamamoto, Takahiko; Ogawa, Masayoshi; Unemura, Chie; Hosono, Motoko; Ito, Hisanori; Sakaguchi, Gaku; Ando, Shigeru; Ohnishi, Shuichi; Kido, Yasuto; Fukushima, Tamio; Miyajima, Hirofumi; Hiroyama, Shuichi; Koyabu, Kiyotaka; Dhuyvetter, Deborah; Borghys, Herman; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5122-5137</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Accumulation of Aβ peptides is a hallmark of Alzheimer's disease (AD) and is considered a causal factor in the pathogenesis of AD.  β-Secretase (BACE1) is a key enzyme responsible for producing Aβ peptides, and thus agents that inhibit BACE1 should be beneficial for disease-modifying treatment of AD.  Here we describe the discovery and optimization of novel oxazine-based BACE1 inhibitors by lowering amidine basicity with the incorporation of a double bond to improve brain penetration.  Starting from a 1,3-dihydrooxazine lead I identified by a hit-to-lead SAR following HTS, we adopted a pKa lowering strategy to reduce the P-gp efflux and the high hERG potential leading to the discovery of II that produced significant Aβ redn. with long duration in pharmacodynamic models and exhibited wide safety margins in cardiovascular safety models.  This compd. II improved the brain-to-plasma ratio relative to I by reducing P-gp recognition, which was demonstrated by a P-gp knockout mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGPZsGRa22ZLVg90H21EOLACvtfcHk0ljdj39InPGzBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptVWhsLo%253D&md5=ac366bddfe3492a0a47ce02918b5ea41</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00002%26sid%3Dliteratum%253Aachs%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DMitsuoka%26aufirst%3DY.%26aulast%3DMasui%26aufirst%3DM.%26aulast%3DKurose%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DUnemura%26aufirst%3DC.%26aulast%3DHosono%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DOhnishi%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DMiyajima%26aufirst%3DH.%26aulast%3DHiroyama%26aufirst%3DS.%26aulast%3DKoyabu%26aufirst%3DK.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.M.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DRational%2520design%2520of%2520novel%25201%252C3-oxazine%2520based%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%253A%2520Incorporation%2520of%2520a%2520double%2520bond%2520to%2520reduce%2520P-gpefflux%2520leading%2520to%2520robust%2520A%25CE%25B2%2520reduction%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5122%26epage%3D5137%26doi%3D10.1021%2Facs.jmedchem.8b00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, M. D.</span></span> <span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1410</span>, <span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+A+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0ljLmahwUw6eng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520A%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidolf, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middleton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolgos, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span> <span> </span><span class="NLM_article-title">In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1616</span>– <span class="NLM_lpage">1632</span>, <span class="refDoi"> DOI: 10.1021/tx300091x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx300091x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=1616-1632&author=R.+A.+Thompsonauthor=E.+M.+Isinauthor=Y.+Liauthor=L.+Weidolfauthor=K.+Pageauthor=I.+Wilsonauthor=S.+Swallowauthor=B.+Middletonauthor=S.+Stahlauthor=A.+J.+Fosterauthor=H.+Dolgosauthor=R.+Weaverauthor=J.+G.+Kenna&title=In+vitro+approach+to+assess+the+potential+for+risk+of+idiosyncratic+adverse+reactions+caused+by+candidate+drugs&doi=10.1021%2Ftx300091x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs</span></div><div class="casAuthors">Thompson, Richard A.; Isin, Emre M.; Li, Yan; Weidolf, Lars; Page, Ken; Wilson, Ian; Swallow, Steve; Middleton, Brian; Stahl, Simone; Foster, Alison J.; Dolgos, Hugues; Weaver, Richard; Kenna, J. Gerry</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1616-1632</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Idiosyncratic adverse drug reactions (IADRs) in humans can result in a broad range of clin. significant toxicities leading to attrition during drug development as well as postlicensing withdrawal or labeling.  IADRs arise from both drug and patient related mechanisms and risk factors.  Drug related risk factors, resulting from parent compd. or metabolites, may involve multiple contributory mechanisms including organelle toxicity, effects related to compd. disposition, and/or immune activation.  In the current study, we evaluate an in vitro approach, which explored both cellular effects and covalent binding (CVB) to assess IADR risks for drug candidates using 36 drugs which caused different patterns and severities of IADRs in humans.  The cellular effects were tested in an in vitro Panel of five assays which quantified (1) toxicity to THLE cells (SV40 T-antigen-immortalized human liver epithelial cells), which do not express P450s, (2) toxicity to a THLE cell line which selectively expresses P 450 3A4, (3) cytotoxicity in HepG2 cells in glucose and galactose media, which is indicative of mitochondrial injury, (4) inhibition of the human bile salt export pump, BSEP, and (5) inhibition of the rat multidrug resistance assocd. protein 2, Mrp2.  In addn., the CVB Burden was estd. by detg. the CVB of radiolabeled compd. to human hepatocytes and factoring in both the max. prescribed daily dose and the fraction of metab. leading to CVB.  Combining the aggregated results from the in vitro Panel assays with the CVB Burden data discriminated, with high specificity (78%) and sensitivity (100%), between 27 drugs, which had severe or marked IADR concern, and 9 drugs, which had low IADR concern, we propose that this integrated approach has the potential to enable selection of drug candidates with reduced propensity to cause IADRs in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFG8lfWXT4vLVg90H21EOLACvtfcHk0ljLmahwUw6eng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqs70%253D&md5=e657aaf23d4efc5466bca68dee95bded</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Ftx300091x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx300091x%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DR.%2BA.%26aulast%3DIsin%26aufirst%3DE.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWeidolf%26aufirst%3DL.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DMiddleton%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DA.%2BJ.%26aulast%3DDolgos%26aufirst%3DH.%26aulast%3DWeaver%26aufirst%3DR.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26atitle%3DIn%2520vitro%2520approach%2520to%2520assess%2520the%2520potential%2520for%2520risk%2520of%2520idiosyncratic%2520adverse%2520reactions%2520caused%2520by%2520candidate%2520drugs%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2012%26volume%3D25%26spage%3D1616%26epage%3D1632%26doi%3D10.1021%2Ftx300091x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">Representative thiazine-based BACE1 inhibitors:</p></div><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, N.</span>; <span class="NLM_string-name">Ueda, K.</span>; <span class="NLM_string-name">Itoh, N.</span>; <span class="NLM_string-name">Suzuki, S.</span>; <span class="NLM_string-name">Sakaguchi, G.</span>; <span class="NLM_string-name">Kato, A.</span>; <span class="NLM_string-name">Yukimasa, A.</span>; <span class="NLM_string-name">Hori, A.</span>; <span class="NLM_string-name">Kooriyama, Y.</span>; <span class="NLM_string-name">Haraguchi, H.</span>; <span class="NLM_string-name">Yasui, K.</span>; <span class="NLM_string-name">Kanda, Y.</span></span> <i>Preparation of 2-Amino-4-phenyl-4,5-dihydro-5H-1,3-thiazine Derivatives and Related Compounds for Treatment of Alzheimer’s Disease</i>. WO <span class="NLM_patent">2008133273 A1</span> November 6, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=N.+Kobayashi&author=K.+Ueda&author=N.+Itoh&author=S.+Suzuki&author=G.+Sakaguchi&author=A.+Kato&author=A.+Yukimasa&author=A.+Hori&author=Y.+Kooriyama&author=H.+Haraguchi&author=K.+Yasui&author=Y.+Kanda&title=Preparation+of+2-Amino-4-phenyl-4%2C5-dihydro-5H-1%2C3-thiazine+Derivatives+and+Related+Compounds+for+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DN.%26jtitle%3DPreparation%2520of%25202-Amino-4-phenyl-4%252C5-dihydro-5H-1%252C3-thiazine%2520Derivatives%2520and%2520Related%2520Compounds%2520for%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBell, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span> <span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with anorally available, non-peptidic β-secretase inhibitor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">16507</span>– <span class="NLM_lpage">16516</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+S.+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+anorally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lifz-zgla_GCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DLaBell%26aufirst%3DE.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520anorally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span> <span> </span><span class="NLM_article-title">Comparison of two different methods for measurement of amyloid-β peptides in cerebrospinal fluid after BACE1inhibition in a dog model</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.3233/JAD-130599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.3233%2FJAD-130599" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=39-48&author=H.+Borghysauthor=T.+Jacobsauthor=B.+Van+Broeckauthor=L.+Dillenauthor=D.+Dhuyvetterauthor=H.+Gijsenauthor=M.+Mercken&title=Comparison+of+two+different+methods+for+measurement+of+amyloid-%CE%B2+peptides+in+cerebrospinal+fluid+after+BACE1inhibition+in+a+dog+model&doi=10.3233%2FJAD-130599"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3233%2FJAD-130599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130599%26sid%3Dliteratum%253Aachs%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DJacobs%26aufirst%3DT.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DDillen%26aufirst%3DL.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3DComparison%2520of%2520two%2520different%2520methods%2520for%2520measurement%2520of%2520amyloid-%25CE%25B2%2520peptides%2520in%2520cerebrospinal%2520fluid%2520after%2520BACE1inhibition%2520in%2520a%2520dog%2520model%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2013%26volume%3D38%26spage%3D39%26epage%3D48%26doi%3D10.3233%2FJAD-130599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dedrick, R.
L.</span></span> <i>J. Pharmacokinet. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>, <span class="refDoi"> DOI: 10.1007/BF01059667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1007%2FBF01059667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=4787619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADyaE2cXktVSjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dedrick%2C+R.%0AL.+J.+Pharmacokinet.+Biopharm.+1973%2C+1%2C+435%2C+10.1007%2FBF01059667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Animal scale-up</span></div><div class="casAuthors">Dedrick, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">435-61</span>CODEN:
                <span class="NLM_cas:coden">JPBPBJ</span>;
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    </div><div class="casAbstract">A discussion and review with 48 refs. on the relation of the pharmacokinetics of any given drug between one species and another.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxc7ybeYNg6LVg90H21EOLACvtfcHk0lifz-zgla_GCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXktVSjsLg%253D&md5=e1e39e0a15f73685fc1139fb1b55cf45</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2FBF01059667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01059667%26sid%3Dliteratum%253Aachs%26aulast%3DDedrick%26aufirst%3DR.%2BL.%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharm.%26date%3D1973%26volume%3D1%26spage%3D435%26doi%3D10.1007%2FBF01059667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de
Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den Bossche, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span> <span> </span><span class="NLM_article-title">Optimization of 1,4-oxazineβ-secretase 1 (BACE1) inhibitors toward a clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5292</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00304</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVCgt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5292&author=H.+J.%0AM.+Gijsenauthor=S.+A.+Alonso+de%0ADiegoauthor=M.+De+Cleynauthor=A.+Garcia-Molinaauthor=G.+J.+Macdonaldauthor=C.+Martinez-Lamencaauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=F.+J.+R.+Romboutsauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=S.+Van+Brandtauthor=D.+Van+den+Bosscheauthor=M.+Van+Goolauthor=N.+Austinauthor=H.+Borghysauthor=D.+Dhuyvetterauthor=D.+Moechars&title=Optimization+of+1%2C4-oxazine%CE%B2-secretase+1+%28BACE1%29+inhibitors+toward+a+clinical+candidate&doi=10.1021%2Facs.jmedchem.8b00304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate</span></div><div class="casAuthors">Gijsen, Harrie J. M.; Alonso de Diego, Sergio A.; De Cleyn, Michel; Garcia-Molina, Aranzazu; Macdonald, Gregor J.; Martinez-Lamenca, Carolina; Oehlrich, Daniel; Prokopcova, Hana; Rombouts, Frederik J. R.; Surkyn, Michel; Trabanco, Andres A.; Van Brandt, Sven; Van den Bossche, Dries; Van Gool, Michiel; Austin, Nigel; Borghys, Herman; Dhuyvetter, Deborah; Moechars, Diederik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5292-5303</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In previous studies, the introduction of electron withdrawing groups to 1,4-oxazine BACE1 inhibitors reduced the pKa of the amidine group, resulting in compd. 2 that showed excellent in vivo efficacy, lowering Aβ levels in brain and CSF.  However, a suboptimal cardiovascular safety margin, based on QTc prolongation, prevented further progression.  Further optimization resulted in the replacement of the 2-fluoro substituent by a CF3-group, which reduced hERG inhibition.  This has led to compd. 3, with an improved cardiovascular safety margin and sufficiently safe in GLP toxicity studies to progress into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF682roZxPn7Vg90H21EOLACvtfcHk0lhtpSlfK2mF2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVCgt7zP&md5=f6e061004a3c5ad98b817ddd198940c7</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00304%26sid%3Dliteratum%253Aachs%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DGarcia-Molina%26aufirst%3DA.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVan%2Bden%2BBossche%26aufirst%3DD.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DMoechars%26aufirst%3DD.%26atitle%3DOptimization%2520of%25201%252C4-oxazine%25CE%25B2-secretase%25201%2520%2528BACE1%2529%2520inhibitors%2520toward%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5292%26doi%3D10.1021%2Facs.jmedchem.8b00304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T.</span></span> <span> </span><span class="NLM_article-title">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">921</span>– <span class="NLM_lpage">931</span>, <span class="refDoi"> DOI: 10.1517/17425250903042318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=10.1517%2F17425250903042318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=19519283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=921-931&author=D.+A.+Priceauthor=J.+Blaggauthor=L.+Jonesauthor=N.+Greeneauthor=T.+Wager&title=Physicochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes%3A+a+review&doi=10.1517%2F17425250903042318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical drug properties associated with in vivo toxicological outcomes: a review</span></div><div class="casAuthors">Price, David A.; Blagg, Julian; Jones, Lyn; Greene, Nigel; Wager, Travis</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">921-931</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The genesis of any toxicol. or safety outcome is multifactorial and complex; for this reason, it can be difficult for drug discovery projects to factor the avoidance of toxicity outcomes into their target design.  A focus on readily measurable parameters from high-throughput in vitro assays (e.g., primary potency, clearance) is easier to handle and have become the mainstays of drug discovery projects.  However, the fundamental origins of adverse safety or toxicity findings can be considered as deriving from four parameters, all of which are in the control of the drug designer.  These can be described as primary pharmacol., off target pharmacol., the presence of a defined structural fragment that can be assocd. with adverse outcomes and the overall physicochem. properties of the mol. that may predispose it to adverse outcomes.  In the drug discovery community, there has been recognition for many years of the influence of physicochem. drug properties (in particular lipophilicity) on the toxicol. profile of compds., and recent research is now beginning to quantify that risk in a probabilistic sense.  This review focuses on the overall properties of classes of mols. that are assocd. with an increased probability of adverse outcomes in in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU8kwwUsaFIrVg90H21EOLACvtfcHk0lhtpSlfK2mF2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVCjtb0%253D&md5=bd1cca3634afda14de2f8aa115d7d55e</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1517%2F17425250903042318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250903042318%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DL.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DWager%26aufirst%3DT.%26atitle%3DPhysicochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%253A%2520a%2520review%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2009%26volume%3D5%26spage%3D921%26epage%3D931%26doi%3D10.1517%2F17425250903042318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JT3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JT3','PDB','6JT3'); return false;">PDB: 6JT3</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01140">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_88074"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01140">10.1021/acs.jmedchem.9b01140</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Toxicokinetic parameters of <b>5</b> in rat and dog, experimental procedures for in vivo cardiovascular safety study, human dose and PK projections, <sup>1</sup>H NMR, <sup>13</sup>C NMR, <sup>19</sup>F–<sup>1</sup>H HOESY data for <b>5</b>, and crystallographic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01140/suppl_file/jm9b01140_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES strings, BACE1 IC<sub>50</sub>, and cellular Aβ<sub>40</sub> IC<sub>50</sub> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01140/suppl_file/jm9b01140_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01140/suppl_file/jm9b01140_si_001.pdf">jm9b01140_si_001.pdf (1.44 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01140/suppl_file/jm9b01140_si_002.csv">jm9b01140_si_002.csv (0.42 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB accession code for the X-ray structure of <b>5</b> bound to human BACE1 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6JT3">6JT3</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01140%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-20%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01140" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1009KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994f977edad94e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
